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The liberation of zinc from intracellular stores during pathophysiological conditions, 
especially those in which reactive oxygen and nitrogen species have been implicated, is central 
to the progression of neuronal injury.  In addition, cellular efflux of a second ionic species, 
potassium, is similarly responsible for facilitating apoptotic cell death downstream of the initial 
oxidant-induced zinc liberation. Potassium efflux is mediated by Kv2.1-encoded potassium 
channels in apoptotic neurons.  Here, I have characterized several critical molecular components 
that link zinc
 
liberation to the loss of cytoplasmic potassium
 
following oxidative injury.  First, 
electrophysiological and viability studies using Kv2.1 channel mutants identified a p38 
phosphorylation site at serine 800 (S800) that is required for Kv2.1 membrane insertion, 
potassium current enhancement, and cell death.  In addition, a phospho-specific antibody for 
S800 detected a p38-dependent increase in Kv2.1 phosphorylation in apoptotic neurons, and 
reveals phosphorylation of S800 in immunopurified channels incubated with active p38.   Next, I 
present data indicating that an N-terminal tyrosine of Kv2.1 (Y124), which is targeted by src, is 
also critical for the apoptotic current surge.  These latter studies suggest that Y124 works in 
concert with the C-terminal serine (S800) target of p38 MAPK to regulate Kv2.1-mediated 
current enhancement.  While zinc was previously shown to activate p38 and src, I demonstrate 
here that this metal inhibits cytoplasmic protein tyrosine phosphatase ε (Cyt-PTPε), which 
targets Y124 and antagonizes the actions of src.  Therefore, I have identified two requisite 
phosphorylation sites on Kv2.1, at Y124 and S800, that cooperatively mediate apoptotic 
potassium current enhancement.  Importantly, disruption of either phosphorylation event is 
neuroprotective.  The work presented here provides a more complete understanding of neuronal 
apoptotic processes by revealing the intracellular signaling events linking intracellular zinc 
liberation and cytoplasmic potassium efflux.   
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1.  INTRODUCTION 
 
 1.1  Overview 
 
Zinc is a ubiquitous, essential metal required for normal cell function, including the 
regulation of protein structure and function (Frederickson et al., 2005), and modulation of 
neurotransmission (Frederickson and Bush, 2001). Zinc also has an important role as an ionic 
second messenger (Pearce et al., 2000; Yamasaki et al., 2007).  Although Zn2+ is present in all 
eukaryotic cells, the concentration of Zn2+ in the mammalian brain is particularly high (~150µM) 
(Weiss et al., 2000). Intracellular free, or “chelatable” Zn2+ concentrations, however, are in the 
picomolar to low nanomolar levels under normal conditions, because of the precise regulation of 
this metal by ionic transport mechanisms, its compartmentalization in organelles, and the 
presence of a large number of metal binding proteins (Frederickson et al., 1989; Sensi et al., 
1997).  Nonetheless, pathological conditions that are accompanied by the generation of reactive 
oxygen and nitrogen species (ROS, RNS) can severely disrupt intracellular Zn2+ homeostasis, 
producing excess free intracellular Zn2+ and triggering the activation of cell death cascades in 
neurons and other cells (Choi and Koh, 1998; Aizenman et al., 2000a; Pal et al., 2004; Capasso 
et al., 2005). 
  
Another essential ion under tight cellular regulation is potassium.  K+ is the single most 
abundant free intracellular cation (~140mM), while its extracellular concentration is relatively 
low (~4mM). This concentration gradient is maintained primarily by the Na+/K+-ATPase pump, 
with contributions from various other ionic transport mechanisms (Panayiotidis et al., 2006).  
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This concentration gradient drives the efflux of intracellular potassium when permeable routes 
for ionic movement, such as voltage-gated K+ channels, are made available.  Importantly, 
increasing evidence supports the notion that these gateways for K+ efflux are indispensable 
mediators of the execution phase of neuronal apoptosis (Yu, 2003a).  When the intracellular K+ 
concentration decreases during pathophysiological conditions, cell death programs can be 
completed (Bortner and Cidlowski, 2007).  Until recently, dysregulation of either Zn2+ or K+ 
were often considered in isolation within the context of neuronal injury.  However, it is now 
known that the sequential disruption in the homeostatic regulation of both these ions is part of a 
continuum along a common apoptotic signaling pathway (Pal et al., 2004).  In this dissertation, I 
sought to more completely characterize the intracellular signaling events connecting Zn2+ and K+ 
dysregulation that regulate oxidant-induced neuronal apoptosis. 
 
1.2  Apoptosis. 
 
Apoptosis is a form of programmed cell death in multicellular organisms associated with 
distinct biochemical signaling events.  Apoptosis was originally described in anatomical terms 
(Kerr et al., 1972), as these biochemical signaling events lead to characteristic morphological 
changes including cell shrinkage, membrane blebbing, chromatin condensation, loss of cell 
attachment, and DNA fragmentation (Taylor et al., 2008). The regulated signaling network and 
the resulting morphological changes normally serve to dispose of unwanted cells in a manner 
that elicits minimal damage to the immediate extracellular environment and neighboring cells.   
This is achieved by signaling to phagocytes via the externalization of the plasma membrane 
associated phosphatidylserine (Martin et al., 1995).  Recruited phagocytes then serve to engulf 
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and remove apoptotic cell remains, protecting the nearby extracellular environment (Kerr et al., 
1972).  Efficient removal of apoptotic debris distinguishes this form of cell death from necrosis, 
which is generally regarded as an acute traumatic insult leading to a disruption in membrane 
integrity and release of cellular contents into the extracellular space.   Thus, one overall objective 
of apoptosis is to avoid necrotic cell lysis, as it inevitably leads to an inflammatory immune 
response, and further exacerbation of the initial injury.  Because the wide variety of cell injury 
processes can result in both traditional apoptotic and necrotic morphologies, it is critical to 
characterize the biochemical signaling events when defining a particular form of cell death.  For 
instance, our laboratory has described both caspase-dependent (McLaughlin et al., 2001) and 
caspase-independent (Du et al., 2002; Zhang et al., 2007) cell death pathways resulting from the 
liberation of intracellular Zn2+ by two distinct injurious stimuli.  Since the term “apoptosis” was 
coined (Kerr et al., 1972), research has characterized a wide range of apoptotic biochemical 
signaling cascades, some conserved and some unique to specific pathophysiological 
circumstances. 
  
Much attention has been given to cell death signaling events mediated by mitochondria, 
as many pro- and anti-apoptotic signaling molecules function within this organelle to ultimately 
determine cell fate.  For instance, the so-called “intrinsic” pathway is initiated by severe cellular 
stressors such as growth factor withdrawl, DNA damage and endoplasmic reticulum (ER)-stress 
(Taylor et al., 2008).  The intrinsic pathway is primarily regulated by the actions of the β cell 
lymphoma (BCL-2) protein family.  The BCL-2 family is made up of three subfamilies (either 
pro- or anti-apoptotic) containing between one and four BCL-2 homology (BH) domains (Taylor 
et al., 2008).  When the injurious stimulus is sufficient to overcome inhibition by the anti-
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apoptotic BCL-2 family members, pro-apoptotic proteins, such as BAK and BAX, have been 
proposed to form oligomeric channels in mitochondrial outer membranes, presumably permitting 
the release of cytochrome c into the cytoplasm (Riedl and Salvesen, 2007).  Cytochrome c then 
binds the cytoplasmic protein Apaf-1, forming the cell death signaling complex known as the 
apoptosome, which is necessary for activation of caspase 9 (Riedl and Salvesen, 2007).  Caspase 
9, in addition to caspase 2, 8 and 10 function as initiator caspases, or cysteine proteases that 
cleave effector caspases. Effector caspases are normally present in the cytoplasm as inactive 
precursor proteins, or pro-caspases, but are activated following proteolytic cleavage of the pro-
peptide domain.   Effector caspases (3, 6, and 7) then cleave other cellular substrates such as the 
actin cytoskeleton, nuclear envelope, and cell adhesion sites, resulting in apoptosis (Taylor et al., 
2008).  In contrast to the intrinsic pathway, the “extrinsic” pathway is activated when death-
promoting ligands, such as Fas ligand (FasL) or Tumor necrosis factor α (TNFα), bind to 
membrane resident death receptors.  Following ligand binding, adaptor proteins associated with 
the receptors recruit and promote activation of caspase 8, which can bypass the mitochondria and 
activate caspase 3 and 7 directly. Regardless of which pathway is initiated, the bulk of death-
inducing proteolytic events observed during apoptosis are carried out by activated caspase 3, 
caspase 6 and caspase 7 (Creagh et al., 2003).  Furthermore, not only have extrinsic and intrinsic 
pathways been shown to converge in certain cell death paradigms, but various forms of caspase-
independent cell death have also been described (Taylor et al., 2008).  In this thesis, I will 
describe the contribution of Kv2.1-encoded K+ channels downstream of intracellular Zn2+ 
liberation during caspase dependent neuronal apoptosis (McLaughlin et al., 2001) via a relatively 
unexplored regulatory mechanism of cell death. 
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1.3  Oxidative stress and neurotoxicity. 
  
Despite the variety of biochemical signaling cascades implicated in neuronal injury, there 
is considerable evidence suggesting that oxidative stress is a critical component of apoptotic cell 
death. Oxidative stress results from the excess production of reactive oxygen species (ROS) due 
to dysregulation in the normal balance between cellular oxidant production and anti-oxidant 
mechanisms.  ROS are a family of oxygen containing molecules, some of which have an 
unpaired electron, and can be particularly damaging to cellular components such as proteins, 
lipids and DNA.  ROS include superoxide anion (O2.-), hydoxyl radical (OH.), and hydrogen 
peroxide (H2O2).  Superoxide also damages cellular components by readily reacting with nitric 
oxide (NO) to form the highly reactive peroxynitrite (ONOO-), a member of the reactive nitrogen 
species (RNS) family.  Similar to studies of apoptosis, investigations of ROS- and RNS-
mediated neuronal injury have also widely implicated mitochondria, as deficits in the energy 
generating electron transport chain are linked to ROS generation.  Indeed, ROS production is a 
defining characteristic of several Parkinson’s disease animal models, such as exposure to 
rotenone or 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine (MPTP) (Mattson, 2000).  Together, 
oxidative and nitrative stress can trigger cellular injury and apoptosis, and have been implicated 
in the pathogenesis of many additional acute and chronic neurodegenerative conditions, 
including stroke, epilepsy, Alzheimer’s disease and amyotrophic lateral sclerosis (Shibata and 
Kobayashi, 2008).  Indeed, treatment with antioxidants such as glutathione, ascorbic acid and 
superoxide dismutase is sometimes sufficient to protect neurons in in vitro and in vivo models of 
ischemia (Mattson, 2000), and in in vitro models of Alzheimer’s disease, Parkinson’s disease and 
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amyotrophic lateral sclerosis (Di Matteo and Esposito, 2003).   The mechanism by which 
particular cellular populations in these disease states are vulnerable to oxidative stress is an area 
of current, intense investigation.  It is important to mention, however, that ROS are not always 
associated with injury, and that they also participate in signaling processes important for normal 
physiological responses, including proliferation and survival (Tonks et al., 2006).  
 
1.4  Oxidative liberation of intracellular Zn2+.  
 
Of the total Zn2+ content in the brain, only 10% is free or chelatable and is restricted to a 
population of glutamate-containing synaptic vesicles (Frederickson et al., 1989).  The majority of 
the cellular Zn2+ is complexed to proteins such as metallothionein (MT), Zn2+ finger-containing 
transcription factors (Frederickson et al., 2005; Maret and Krezel, 2007), and other functional 
proteins, like kinases and phosphatases (Korichneva, 2006).  Nonetheless, Zn2+ can be liberated 
from some of these stores by either oxidative stimuli or NO-related species (Maret, 1994; 
Aizenman et al., 2000b; Frederickson et al., 2002; Frederickson et al., 2004).  Moreover, 
products of lipid peroxidation have also been recently shown to trigger intracellular Zn2+ release, 
thereby linking a common oxidative stress product directly to Zn2+-mediated signaling (Hao and 
Maret, 2006).  Maret and Vallee (1998) have pointed out that MT-bound Zn2+ is readily released 
by thiol oxidants, because of MT’s relatively negative redox potential (-366 mV).  Hence, even 
though this metalloprotein has a relatively high affinity for Zn2+ (Kd=1.4 x 10-13 M), oxidants 
acting as cellular signals can rapidly and effectively induce the transfer of Zn2+ from MT to other 
proteins with lower affinities for this metal (Maret, 2006).  Under injurious oxidant conditions 
however, the liberated Zn2+ becomes a significant trigger for neuronal injury (Pal et al., 2004). 
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1.5  Role of Zn2+ in neuronal injury.   
 
Zn2+ has been referred to as the “calcium of the twenty-first century” (Frederickson et al., 
2005), as many of the roles of Zn2+ in the central nervous system have just begun to be fully 
appreciated, including its newly recognized function as a second messenger (Pearce et al., 2000; 
Yamasaki et al., 2007).  Nonetheless, Zn2+-mediated neurodegeneration studies now span nearly 
two decades since this metal was first shown to be directly toxic to neurons (Yokoyama et al., 
1986; Choi et al., 1988).  In nearly all of the initial studies in this field, neuronal cell death was 
proposed to be mediated by the influx of synaptically released Zn2+ into cells (Weiss et al., 
1993).  Zn2+-induced injury was shown to be blocked by antagonists of potential entry sites for 
this metal, such as Ca2+-permeable voltage- and glutamate-gated ion channels, as well as by cell-
impermeant metal chelators (Colvin et al., 2003).  The balance between the physiological and 
pathophysiological actions of Zn2+ closely resembles those which have been described for Ca2+ 
(Choi, 1995).  Zn2+, like Ca2+, is a selective ligand for a metabotropic receptor (Hershfinkel et 
al., 2001; Hershfinkel et al., 2007), can be sequestered by intracellular organelles such as 
mitochondria (Sensi et al., 2003), is bound to metal chaperone proteins such as metallothionein 
(MT) (Maret, 2006) and is regulated by plasma membrane transporters (Sekler et al., 2007), all 
of which work in unison to maintain intracellular Zn2+ homeostasis, similar to Ca2+ regulation 
(Colvin et al., 2003).  Additionally, like Ca2+, Zn2+ is an important component of several 
molecular signaling pathways (Frederickson et al., 2005).  Interestingly, a recent study suggested 
that some of the previously proposed neurotoxic mechanisms of intracellular Ca2+ dysregulation 
may be actually due to Zn2+ (Stork and Li, 2006).   
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Cellular Zn2+ influx has been associated with neuronal damage resulting from ischemia, 
trauma and epilepsy, among other disorders.  Free (chelatable) Zn2+ is present in synaptic 
vesicles (Frederickson et al., 1989; Frederickson et al., 1992), and is generally believed to be 
synaptically released and enter postsynaptic neurons (Weiss et al., 2000).  Despite these reports, 
some controversy exists, as reports have also provided evidence suggesting that vesicular Zn2+ 
might not be released into the synapse (Kay, 2003; Lavoie et al., 2007).  Also, intracellular Zn2+ 
accumulation and neurotoxicity is sustained in mice lacking vesicular Zn2+ (Lee et al., 2000; Lee 
et al., 2003), demonstrating synaptic Zn2+ is not the only death-inducing source of this metal.  
Regardless of the origin of Zn2+, the significance of Zn2+-mediated neuronal injury is best 
exemplified by the observation that Zn2+ chelation is neuroprotective in in vivo models of 
neuronal injury, including ischemia (Calderone et al., 2004; Choi et al., 2006) and head trauma 
(Suh et al., 2000).   
 
1.6  Mechanisms of Zn2+ neurotoxicity.   
 
The mechanisms by which an increase in intracellular free Zn2+ induces neuronal cell 
death in neurodegenerative disorders are not completely understood. Zn2+ is redox inactive 
(Maret, 2006) and, as such, is likely to be relatively non-toxic by itself.  Several mechanisms 
have therefore been suggested to account for the toxic actions of this metal.  (Manev et al., 1997) 
first proposed that Zn2+ can enter mitochondria and induce the release of oxygen-derived free 
radicals.  Zn2+ also affects several key components of mitochondrial function (Kleiner, 1974), in 
addition to inducing permeability transition (Wudarczyk et al., 1999; Jiang et al., 2001), 
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inhibiting mitochondrial movement (Malaiyandi et al., 2005), and activating mitochondrial 
multi-conductance channels associated with cell death signaling molecules (Bonanni et al., 
2006).  Furthermore, Zn2+ can inhibit glycolysis and deplete nicotinamide adenine dinucleotide 
(NAD+), an essential coenzyme that regulates cellular redox reactions (Sheline et al., 2000).  
Although each of these studies has contributed significantly to our understanding of Zn2+ 
toxicity, the specific signaling pathways that contribute to Zn2+-induced injuries are incomplete, 
and remain important and critical areas of study.     
 
 Zn2+-associated cellular injury has been implicated in both caspase-dependent and 
independent cell death pathways (Kim et al., 1999; McLaughlin et al., 2001; Du et al., 2002; 
Bossy-Wetzel et al., 2004).  The activation of these divergent pathways has been linked to the 
intensity of Zn2+ exposure (Kim et al., 1999).  Other factors, such as regulation of Zn2+-
dependent transcription factors (Park and Koh, 1999), activation of kinases (Noh et al., 1999; 
McLaughlin et al., 2001; Du et al., 2002) and generation of reactive oxygen species (Noh and 
Koh, 2000), as well as the release of apoptosis-inducing molecules (Jiang et al., 2001) and 
activation of death induction proteins (Bonanni et al., 2006), likely determine the cellular 
processes by which neurons die following Zn2+ exposure.  Importantly, Zn2+ can also prevent 
apoptosis under certain circumstances (Fraker and Telford, 1997), and the depletion of this metal 
can be deleterious to cells (Ahn et al., 1998).   
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1.7  Potassium channels and apoptosis. 
  
Potassium channels are integral proteins that selectively permit potassium ions to cross 
the cell membrane.  Potassium channels are comprised of pore-forming α subunits that assemble 
into homo- or hetero-tetramers and are sometimes associated with auxillary regulatory β subunits 
(Trimmer and Rhodes, 2004).  Over 100 genes encoding K+ channel α subunits have been 
identified, making them the most diverse group of ion channels in the mammalian genome 
(Trimmer and Rhodes, 2004).  Despite this diversity, all K+ channels share a homologous pore 
loop domain that is responsible for K+ ion selective permeability (Choe, 2002).  Potassium 
channels are widely expressed and contribute to a variety of neuronal functions, including 
establishing cellular resting potential and repolarization during an action potential.   
 
There are four major classes of K+ channels: Ca2+-activated (KCa), inward rectifying (Kir), 
tandem pore domain (K2P), and voltage gated (Kv), characterized as such according to their 
structure and function (Choe, 2002).  Calcium-activated potassium channels permeate K+ ions in 
response to intracellular Ca2+ and contain one pore and six transmembrane domains (Burg et al., 
2006).  Inward rectifier channels contain two transmembrane domains, one pore domain, and 
pass K+ current more easily into the cytoplasm than into the extracellular space, contributing to a 
cells resting membrane potential (Burg et al., 2006).  Tandem pore domain channels or “leak 
channels” contain four transmembrane domains and two pore domains, are constitutively open 
and contribute to the negative resting membrane potential of neurons (Burg et al., 2006).  
Voltage-gated (Kv) K+ channels contain six transmembrane domains (S1-S6), one pore domain, 
and are permeable to K+ ions in response to changes in transmembrane voltage (Burg et al., 
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2006) detected by the voltage-sensing S4 domain (Cha et al., 1999). The N-terminal 
tetramerization or T1 domain is a common component in all Kv channels, and is required for 
assembly of individual subfamily-specific α subunits and formation of functional channels 
(Papazian, 1999).  In addition to channel assembly, the T1 domain is the site of β auxillary 
subunit binding in Kv1 and Kv4 channels, which regulates channel gating, trafficking and 
subcellular localization (Li et al., 2006).  Certain Kv channels can adopt an inactivated 
conformation in which K+ ion movement is blocked despite a change in membrane voltage.  Two 
primary types of inactivating Kv channels have been identified.  While rapidly inactivating (A-
type) channels display millisecond inactivation, delayed rectifying channels take seconds to 
inactivate (Pongs et al., 1999).   Several mechanisms of inactivation have been recognized.  C- 
and P-type inactivation is correlated with a structural rearrangement of the α subunit C-
terminals, while N-type inactivation is mediated by “ball and chain” domains of the amino 
terminal of certain α and β subunits (Pongs et al., 1999). 
 
1.7.1  Kv2.1 
  
Voltage-gated potassium channels play a critical role in cell function by governing 
processes such as maintaining proper ionic gradients and regulating cellular excitability.  There 
are 12 subfamilies of Kv channels, encoded by distinct genes (Gutman et al., 2005), that are 
composed of the aforementioned six transmembrane and one pore forming domain in addition to 
N- and C-terminal cytoplasmic tails (Long et al., 2005).  Kv2.1, a product of the human KCNB1 
gene, is the primary delayed-rectifying K+ channel expressed in most neurons.  In cortical and 
hippocampal neurons, Kv2.1 α homotetramers are localized in large somatodendritic clusters 
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(Trimmer, 1991).  Kv2.1 does not generally participate in neuronal repolarization during single 
action potentials due to an elevated voltage-dependent activation threshold and slow activation 
kinetics (Du et al., 2000; Surmeier and Foehring, 2004).  Instead, under normal conditions Kv2.1 
activates slowly following depolarization and functions to suppress neuronal excitability during 
repeated, high frequency synaptic stimulation (Misonou et al., 2005).   
 
Both Kv2.1 intracellular termini play important roles in regulating channel function, as 
phosphorylation and dephosphorylation events on the intracellular termini have been shown to 
modulate Kv2.1 gating and subcellular localization.  A number of serine, threonine and tyrosine 
kinases are known to target and modify Kv2.1 channels.  The majority of well described 
phosphorylation and dephosphorylation events reported for Kv2.1 had been shown to strongly 
influence channel gating and neuronal excitability (Park et al., 2006), but not apoptosis.  
Following an apoptotic insult, alterations in the voltage-dependence of membrane-resident 
channels have not been observed, a phenomenon that has been reported by others to accompany 
non-lethal neuronal injury (Misonou et al., 2004; Misonou et al., 2005a).  In those cases, 
calcineurin-dependent dephosphorylation of multiple intracellular sites on Kv2.1 participate in 
the graded regulation of channel activation. The dynamic regulation of calcineurin-sensitive sites 
on Kv2.1 is responsible for suppressing neuronal firing during periods of high activity (Misonou 
et al., 2005b), as dephosphorylation of these sites lowers the voltage threshold for channel 
activation (Mohapatra et al., 2007).  This hyperpolarizing shift in Kv2.1 activation has been 
proposed to be a neuroprotective response to excitotoxic injury induced by epileptic seizures and 
ischemic insults (Misonou et al., 2005b).   
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An association between the Kv2.1 C-terminal and an undefined retention protein is 
hypothesized to regulate the clustered subcellular distribution in neurons (O'Connell et al., 2006).  
Interestingly, single Kv2.1 channels are remarkably mobile within channel clusters, and 
sometimes randomly move between individual clusters (Tamkun et al., 2007), indicating that a 
sustained physical association between Kv2.1 and an unknown scaffolding protein does not 
govern clustering.  In addition, calcineurin dephosphorylation of the intracellular termini 
regulates the cluster dispersion accompanying high frequency neuronal activity (Misonou et al., 
2004).  Accordingly, it has been proposed Kv2.1 clusters are maintained by an actin cytoskeleton 
perimeter fence, which contains channel retention proteins that can only associate with Kv2.1 
when the C-terminal calcineurin-sensitive sites are phosphorylated (Tamkun et al., 2007).  
Following dephosphorylation, the protein associated is disrupted and Kv2.1 channels are able to 
freely travel beyond the cytoskeleton boundary. In addition to phosphorylation-dependent 
membrane localization and channel gating, phosphorylation is also known to affect Kv channel 
trafficking, and likely participates in surface delivery of Kv2.1 to channel containing clusters 
(O’Connell et al., 2006).  The phosphorylation-dependent trafficking of other Kv channels has 
been demonstrated with Kv1.2 following PKA activation in Xenopus oocytes (Huang et al., 
1994) and hERG channels following PKC activation (Cockerill et al., 2007).  In this dissertation, 
I detail multiple Kv2.1 intracellular phosphorylation reactions and their effect on channel 
trafficking and K+ efflux during oxidant-induced neuronal apoptosis. 
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1.7.2  Potassium efflux and apoptosis.   
 
The enhancement of voltage-gated K+ channel activity in injured cells, resulting in K+ 
efflux, has been shown to be a crucial element in apoptotic neuronal death (Yu, 2003a).  Indeed, 
several models of apoptosis have demonstrated K+ efflux as a required event in the cell death 
process (Bortner and Cidlowski, 2007).  In most instances, the molecular mechanism by which 
the K+ current enhancement and/or K+ efflux is achieved has yet to be elucidated.  Regardless, 
increased K+ efflux seems to be a critical component for cell death in many pathological 
circumstances.  Interestingly, blocking K+ efflux via channel inhibition, can also sometimes lead 
to apoptosis (Lauritzen et al., 1997).  For instance, Drosophila Ether-a-go-go (EAG) K+ channels 
have been shown to inhibit apoptosis and increase proliferation (Hegle et al., 2006).  However, 
the anti-apoptotic actions in this instance were attributed to intracellular cell survival signaling 
cascades initiated by a voltage-dependent conformational change in the channel, but not ion flux, 
as non-conducting mutants channels were also protective.  Furthermore, certain K+ channels 
have been shown to facilitate tumor progression and proliferation in cell lines, as 
pharmacological inhibition of K+ channels blocks these effects (Pardo et al., 2005). 
 
It has been proposed that the enhancement of K+ currents during apoptosis leads to a 
decrease in the concentration of this cation in the cytoplasm (Yu et al., 1999).  In fact, the 
intracellular K+ concentration in some apoptotic cells has been estimated to be as low as 30-50 
mM.  This decrease in intracellular K+  acts as a permissive apoptotic signal in both traditional 
intrinsic and extrinsic pathways of apoptosis (Bortner and Cidlowski, 2004), as caspases and 
apoptotic nucleases are activated most efficiently at significantly reduced potassium 
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concentrations (Hughes and Cidlowski, 1999).  Moreover, reduced intracellular K+ is a 
prerequisite for other apoptotic processes, including cell volume decrease, cytochrome c release 
and alterations in mitochondrial membrane potential (Yu, 2003a), while normal intracellular K+  
levels hinder oligomerization of Apaf-1 and assembly of the apoptosome (Cain et al., 2001).  It 
must also be noted that inhibition of both Na+/K+-ATPase and potassium leak channels has been 
shown to contribute to reduced intracellular K+ concentrations during apoptosis (Yu, 2003a; 
Brevnova et al., 2004).  Interestingly, depleting intracellular K+ alone is sometimes sufficient to 
induce apoptosis, as demonstrated in granule neurons, T-lymphocytes and rodent tumor cell lines 
following K+ channel overexpression or K+-selective ionophore treatment (Yu, 2003).  Thus, 
maintaining physiological intracellular potassium levels by blocking K+ channels or increasing 
the extracellular K+ concentration effectively attenuates cell death in many models of neuronal 
apoptosis (Yu et al., 1997; Yu et al., 1998; Yu et al., 1999; Wang et al., 2000; McLaughlin et al., 
2001; Xiao et al., 2001; Bossy-Wetzel et al., 2004; Wei et al., 2004; Redman et al., 2006). 
 
1.8  The zinc-potassium continuum in apoptosis.   
 
Cell death pathways linking intracellular Zn2+ liberation and enhanced K+ currents may 
be widespread (Pal et al., 2004).  Our laboratory has provided a direct link between these two 
phenomena following the release of Zn2+ by thiol oxidants (McLaughlin et al., 2001) and 
peroxynitrite (Pal et al., 2004; Zhang et al., 2004).  More recently we have also reported that 
neurons exposed to microglia-derived ROS and RNS have observable Zn2+ release and a very 
pronounced K+ current surge preceding cell death (Knoch et al., 2008).  While the requirement of 
Zn2+ liberation and K+ efflux have been demonstrated for neuronal cell death (McLaughlin et al., 
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2001; Pal et al., 2003), in this dissertation, I describe important molecular signaling events 
connecting the two phenomena.  Specifically, I will discuss the contribution of three Zn2+-
dependent signaling enzymes: p38 MAPK, src, and the cytoplasmic form of protein tyrosine 
phosphatase epsilon (Cyt-PTPε), and their contribution to the Kv2.1-mediated apoptotic K+ 
current surge. 
 
1.9  Signaling enzymes connecting Zn2+ liberation to K+ efflux.  
 
1.9.1  p38 MAPK 
 
Mitogen activated protein kinases (MAPKs) are serine/threonine kinases that transduce 
environmental signals into cellular responses such as initiation of gene expression, differentiation 
and cell survival/death.  MAPK activation is achieved via dual phosphorylation of conserved 
threonine and tyrosine residues by upstream MAPK kinases (MKKs), which are activated by 
upstream MAPK kinase kinases (MAPKKKs).  Four families of MAPKs: ERK1/2, ERK5, JNKs 
and p38 have been characterized.  Mammalian p38 MAPKs are activated by a variety of cellular 
stressors including exposure to inflammatory cytokines, UV radiation, osmotic stress, and 
oxidative stress (Cuenda and Rousseau, 2007).  There have been four p38 MAPKs identified in 
mammals: p38α, p38β, p38γ, and p38δ, all of which are encoded by different genes (Cuenda and 
Rousseau, 2007).  p38α was the first isoform discovered and was originally characterized as a 38 
kDa protein that displayed increased tyrosine phosphorylation following both endotoxin and 
hyperosmolarity insults (Han et al., 1994).  p38α and p38β are are widely expressed, but very 
abundant in the brain and heart (Han et al., 1996), while p38γ is most highly expressed in 
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skeletal muscle and p38δ is primarily expressed in the testis, pancreas kidney and small intestine 
(Cuenda and Rousseau, 2007).   Each isoform is similarly transiently activated via dual 
tyrosine/threonine phosphorylation, although differential activation of the individual isoforms 
within a single cell is likely to result from a specific stimulus.  Following activation, p38 
phosphorylates both cytosolic and nuclear targets, including transcription factors and other 
proteins involved in cell cycle progression, chromatin remodeling, mRNA stability, and 
cytoskeletal reorganization (Cuenda and Rousseau, 2007).  Due to its originally described role in 
regulating the production of the inflammatory cytokines IL-1 and TNF-α (Lee et al., 1994), p38 
has long been implicated the progression of neurodegenerative processes (Cuenda and Rousseau, 
2007).   However, the exact mechanism by which p38 mediates an apoptotic cellular response is 
unknown.   
 
Incubation of metallothionein, an important intracellular metal binding protein, with the 
cell-permeant thiol oxidant 2,2’-dithiodipyridine (DTDP) results in the oxidation of all 20 
cysteines contained in the protein and release of all bound Zn2+ atoms (Maret and Vallee, 1998).  
Our laboratory utilized DTDP to induce the release of Zn2+ from intracellular metal binding 
proteins in cortical neurons in vitro (McLaughlin et al., 2001).  We observed that DTDP-
liberated Zn2+ was an upstream mediator of neuronal apoptosis via a p38 kinase-dependent 
process (McLaughlin et al., 2001; Aras and Aizenman, 2005; Zhang et al., 2007). Our studies 
have described in detail an apoptotic cell death pathway that is activated by the liberated metal in 
neurons: the intracellular release of Zn2+ is followed by generation of reactive oxygen species 
(ROS) from mitochondria (Sensi and Jeng, 2004) and 12-lipoxygenase (12-LOX) (Zhang et al., 
2004). 12-LOX is an important enzyme in the arachadonic acid (AA) metabolism pathway 
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(Kudo and Murakami, 2002) and is the primary LOX expressed in the brain (Shimizu and Wolfe, 
1990). ROS are a byproduct of AA production via 12-LOX under normal conditions (Dikalov 
and Mason, 2001), and an oxidative cellular environment enhances 12-LOX activity (Shornick 
and Holtzman, 1993), further increasing ROS and facilitating Zn2+-release. 
 
ROS generation leads to the activation of p38 via the upstream apoptosis signal-
regulating kinase 1 (ASK-1) (McLaughlin et al., 2001; Aras and Aizenman, 2005).  ASK-1 is a 
member of the MAPKKK family which activates p38 by phosphorylating the upstream kinases 
MKK3/MKK6 (Ichijo et al., 1997). During normal conditions, ASK1 is inhibited by thioredoxin 
(Trx) via a physical association (Matsukawa et al., 2004).  Trx is a redox-regulatory protein that 
is vulnerable to ROS-induced modifications.  During cell stress, ROS induce the liberation of 
ASK1, which subsequently becomes activated following oligomerization and 
autophosphorylation (Liu and Min, 2002).  Importantly, the generation of ROS likely provides a 
feedback-like stimulus for additional Zn2+ release from metallothionein and other metalloproteins 
in addition to activating ASK-1.  The activation of p38 is followed by an enhancement of 
delayed rectifying, Kv2.1-mediated K+ currents, and finally caspase activation (Pal et al., 2003).   
 
This enhancement of K+ currents is mediated by the N-ethylmaleimide-sensitive factor 
attachment protein receptor (SNARE)-dependent membrane insertion of Kv2.1-encoded 
channels following p38 activation (Pal et al., 2006; Redman et al., 2007), rather than an 
alteration in membrane resident channel activity.  Thus, p38 may be directly phosphorylating 
Kv2.1 leading to plasma membrane insertion.  Phosphorylation-dependent surface delivery is an 
effect that has been demonstrated in other ion channel populations (Hayashi et al., 2000; Yang et 
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al., 2007).  Importantly, another member of the MAPK family, ERK1/2, has been shown to 
directly phosphorylate Kv4.2 resulting in a downregulation of dendritic K+ currents in CA1 
hippocampal pyramidal neurons (Yuan et al., 2002).  However, whether this change in currents 
results from channel trafficking has not been demonstrated (Adams et al., 2000). 
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Figure 1.  Schematic diagram of proposed pathway linking ROS/RNS-mediated liberation of 
intracellular Zn2+ and a subsequent enhancement of Kv2.1-mediated K+ currents.  Increases in 
intracellular Zn2+ lead to activation of p38 via a ROS-dependent activation of ASK-1.  Kv2.1 
channels are inserted in the cell membrane following activation of p38.  Channel membrane 
insertion is a SNARE-dependent process. 
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1.9.2  Src 
 
The Src family of tyrosine kinases consists of 8 distinct proteins involved in a wide 
variety of cellular signaling processes regulating viability, proliferation, migration and 
differentiation (Ingley, 2008).  Src was the first protein tyrosine kinase to be discovered 
(Levinson et al., 1978) and has traditionally been associated with cancer cell transformation and 
the progression of human malignancies (Ishizawar and Parsons, 2004).  However, it has now 
been repeatedly shown that src can affect cell function via non-oncogenic mechanisms.  For 
instance, src, which is highly expressed in the brain (Soriano et al., 1991), affects nervous system 
function by contributing to synaptic plasticity (Maness et al., 1988), neuronal differentiation 
(Ingraham et al., 1989), neurite extension (Maness et al., 1988) and astrocytic gap junction 
closure (Lau, 2005).   Interestingly, src is also known to play an instrumental role in glutamate-
induced neuronal cell death (Khanna et al., 2002), as both src depletion (Paul et al., 2001) and 
pharmacological inhibition of src activity (Lennmyr et al., 2004) is sufficient to reduce injury 
following an ischemic insult.  Because glutamate toxicity contains both excitotoxic and oxidative 
stress components, it is important to note that inducible src activity has been shown to be a 
critical component of the oxidant-dependent pathway of glutamate toxicity (Khanna et al., 2002).  
In this paradigm, glutamate treatment of immature neurons lacking N-methyl-D-aspartate 
(NMDA) receptors generates ROS primarily via inhibition of the glutamate/cystine antiporter 
(Murphy et al., 1989).  This inhibition blocks cellular uptake of cystine, a precursor of the 
antioxidant glutathione, which subsequently leads to ROS-mediated damage.  Further relevant to 
the present study, src is also activated by cytosolic Zn2+ (Wu et al., 2002; Huang et al., 2008), a 
previously mentioned component in oxidant-induced neuronal injury.  
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 Src family tyrosine kinases share similar domain arrangements (N-terminal “unique”, 
SH2, SH3 and catalytic domains) that regulate both substrate targeting and enzymatic activity 
(Martin, 2001).  Src normally assumes a closed or “autoinhibited” inactive state mediated by a 
dual phosphorylation site.  Phosphorylation of the C-terminal tyrosine 527 leads to inactivation 
via an intramolecular interaction with the SH2 domain, guiding the SH3 domain to interact with 
the “linker” that connects SH2 and catalytic domains (Martin, 2001).  The nature of src 
autoinhibition allows for multiple mechanisms of enzymatic activation, such as 
dephosphorylation of tyrosine 527 by a protein tyrosine phosphatase, binding of the SH2 domain 
to another phospho-tyrosine that competes with tyrosine 527, and competitive binding of a 
domain similar to the “linker” to SH3 (Ingley, 2008).  Following disruption of the intramolecular 
interaction by any of these mechanisms, phosphorylation of the catalytic domain tyrosine 416 
then facilitates enzyme activation (Tatosyan and Mizenina, 2000).  Phosphorylation of the 
inhibitory tyrosine 527 is mediated by the kinase Csk (Tatosyan and Mizenina, 2000), a 
cytoplasmic enzyme susceptible to direct Zn2+ inhibition (Huang et al., 2008). 
 
Src has been shown to phosphorylate Kv2.1 at intracellular N-terminal tyrosine 124 
(Y124), leading to upregulation of channel activity (Tiran et al., 2003) during non-injurious 
conditions.  In those studies, Y124 phosphorylation was observed not to affect Kv2.1 gating 
properties (Tiran et al., 2003; Tiran et al., 2006), suggesting src may be regulating the number of 
membrane resident channels via changes in trafficking, as our group has observed with Kv2.1 
surface delivery during neuronal apoptosis (Pal et al., 2006).  Accordingly, here I will 
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characterize the effect of Y124 phosphorylation by src on the apoptotic K+ current surge 
observed during neuronal cell death. 
 
1.9.3  Protein Tyrosine Phosphatase ε  
 
Protein phosphorylation can be reversed through the catalytic activity of protein 
phosphatases.  Specifically, tyrosine phosphorylation via tyrosine kinases is countered by the 
actions of protein tyrosine phosphatases (PTPs).  Protein tyrosine kinases and protein tyrosine 
phosphatases are represented in the human genome by 90 genes and 107 genes, respectively 
(Tonks, 2006).   The majority of active tyrosine phosphatases are either tyrosine-specific or 
target both phosphoserine and phosphothreonine in addition to phosphotyrosine residues.  
Classical PTPs have been defined by either one or two catalytic domains containing the signature 
motif HCX5R, in which the cysteine residue located in the core of the catalytic domain is critical 
for enzymatic function (Tonks, 2006).  This critical cysteine forms a covalent bond with the 
phosphate via nucleophilic attack followed by a break in the substrate phospho-tyrosine bond 
and release of the dephosphoyrlated substrate.  The cysteine-phosphate bond is then hydrolyzed, 
releasing the phosphate and reactivating the phosphatase (Berman-Golan et al., 2008).   
 
The classical PTPs include two major structurally distinct subgroups: transmembrane 
receptor like proteins (RPTPs) and cytosolic, non-transmembrane PTPs.  RPTPs contain a 
ligand-binding extracellular domain, a transmembrane domain and either one or two cytosolic 
phosphatase domains termed D1 and D2.  Studies have shown that in PTPs with two cytosolic 
domains, the catalytic activity resides primarily in the proximal D1 domain, while the distal D2 
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domain is either weakly or entirely inactive, and serves largely a regulatory role (Buist et al., 
1999).  Non-receptor PTPs are characterized by a single catalytic domain flanked by protein 
sequences that determine both phosphatase activity and subcellular localization (Tonks et al., 
2006).  Both RPTPs and non-receptor PTPs are regulated at the protein level by proteolysis, 
ligand-induced dimerization, reversible oxidation of the catalytic cysteine residue and 
phosphorylation (Berman-Golan et al., 2008).  PTPs are also inhibited by endogenous Zn2+ 
following oxidative injury (Ho et al., 2008), Zn2+ itself in cell free preparations (Brautigan et al., 
1981; Haase and Maret, 2003, 2005) and following cellular exposure to exogenous Zn2+ (Haase 
and Maret, 2003, 2005; Kim et al., 2006; Tal et al., 2006).  
 
Protein tyrosine phosphatase epsilon (PTPε) was originally characterized as an RPTP 
containing a typical transmembrane domain and two cytoplasmic catalytic domains (Elson and 
Leder, 1995).  Since then, a cytoplasmic form of PTPε (Cyt-PTPε) has been described that is 
structurally similar to RPTPε, but without a transmembrane domain (Elson and Leder, 1995).  
Both PTPε isoforms are produced from a unique mRNA species transcribed from a single gene 
(PTPre) by alternative promoters (Tanuma et al., 1999).  A third and fourth forms of PTPε, p67 
and p65, are produced from internal initiation of translation from a region common to both 
mRNA isoforms (p67) and calpain-mediated cleavage of the three larger PTPε isoforms (p65) 
(Gil-Henn et al., 2000).  The only structural difference between these four PTPε isoforms is in 
their amino termini, rendering RPTPε membrane bound, Cyt-PTPε localized to the cytoplasm, 
nucleus and plasma membrane, and p67 and p65 localized exclusively to the cytoplasm (Gil-
Henn et al., 2000).  In addition to transcriptional, translational, and proteolytic regulation, PTPε 
is also controlled by dimerization (Toledano-Katchalski et al., 2003), association with tubulin 
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(Sines et al., 2007), or via phosphorylation state (Berman-Golan et al., 2008).  Regulatory 
mechanisms, such as oxidation and Zn2+ inhibition, and their impact on neuronal apoptosis will 
be discussed in greater detail later in the dissertation.   
 
Cyt-PTPε has been shown to dephosphorylate Kv2.1 at intracellular N-terminal tyrosine 
124 (Y124), countering the upregulation of channel activity mediated by src during non-injurious 
conditions (Tiran et al., 2003). Y124 phosphorylation state does not affect Kv2.1 gating 
properties (Tiran et al., 2003; 2006), suggesting Cyt-PTPε and src regulate the number of 
membrane resident channels via changes in trafficking.   In my work, I will describe how, during 
apoptosis, Zn2+ regulates Cyt-PTPε, its known physiological substrate the delayed-rectifier 
voltage-gated potassium channel Kv2.1, and hence neuronal apoptosis.   
 
1.10  Thesis Goals 
 
The goal of my dissertation was to characterize an important signaling pathway 
regulating neuronal apoptosis.  Although Zn2+ and K+ dysregulation have been shown to 
contribute to neuronal cell death, the intracellular signaling processes connecting the two 
phenomena have not been established.  Because earlier studies from our lab indicated that the 
Kv2.1-mediated apoptotic K+ current surge was dependent on p38 activity, and a putative p38 
phosphorylation site was identified at S800 using a proteomic and biochemical based 
phosphorylation prediction program, I first investigated the effect of direct p38 phosphorylation 
of Kv2.1 on the apoptotic process.  The results from these experiments are presented in Chapter 
1.  This chapter represents the contents of a manuscript that has been published (Redman et al., 
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2007).  Next, I examined the effect of a second Kv2.1 phosphorylation site on apoptosis, at 
Y124, which is known to be oppositely modulated by src and Cyt-PTPε under normal conditions.  
The results from these experiments are presented in Chapter 2.  This chapter comprises a 
manuscript currently under review.  Finally, Zn2+ liberation is required for oxidant-induced p38 
activity and known to affect src activity.  However, although some evidence implicates Zn2+-
inhibition of tyrosine phosphatase activity, no direct demonstration of Zn2+-mediated Cyt-PTPε 
inhibition has been shown following oxidative injury.  Thus, I investigated the role of 
intracellular Zn2+ liberation in Cyt-PTPε inhibition.  The results from these studies are also 
presented in Chapter 2.  The present findings, taken together with previous experiments, suggest 
a concurrent, Zn2+-dependent disruption in tyrosine phosphatase activity and enhancement of src 
and p38 activity during apoptosis, thereby ensuring the phosphorylation of both Y124 and S800.  
With this dissertation, I detail how separate Zn2+-dependent signaling pathways converge at 
Kv2.1 to mediate the apoptotic K+ current surge and neuronal death.  In addition, I have included 
another related study in the appendix describing the role of Kv2.1-mediated K+ efflux in 
dopamine-transporter dependent 6-hydroxydopamine neurotoxicity.  This study has also been 
published (Redman et al., 2006). 
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2.  Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1 
 
2.1  Abstract 
 
Kv2.1, the primary delayed rectifying potassium channel in neurons, is extensively 
regulated by phosphorylation.  Previous reports have described Kv2.1 phosphorylation events 
affecting channel gating and the impact of this process on cellular excitability.  Kv2.1, however, 
also provides the critical exit route for potassium ions during neuronal apoptosis via p38 MAPK-
dependent membrane insertion, resulting in a pronounced enhancement of K+ currents.  Here, 
electrophysiological and viability studies using Kv2.1 channel mutants identify a p38 
phosphorylation site at serine 800 (S800) that is required for Kv2.1 membrane insertion, K+ 
current surge, and cell death.  In addition, a phospho-specific antibody for S800 detects a p38-
dependent increase in Kv2.1 phosphorylation in apoptotic neurons, and reveals phosphorylation 
of S800 in immunopurified channels incubated with active p38.  Consequently, phosphorylation 
of Kv2.1 residue S800 by p38 leads to trafficking and membrane insertion during apoptosis, and 
remarkably, the absence of S800 phosphorylation is sufficient to prevent completion of the cell 
death program.  
 
 28 
2.2  Introduction 
 
Enhancement of voltage-gated K+ channel activity, resulting in K+ efflux, is an essential 
step in neuronal apoptosis (Yu, 2003b).  Blocking K+ channels, or increasing the extracellular K+ 
concentration, effectively attenuate cell death in many apoptotic models (Bortner et al., 1997; 
Hughes et al., 1997; Yu et al., 1997; Zaks-Makhina et al., 2004; Grishin et al., 2005), including 
oxidant exposure in cortical and midbrain dopaminergic neurons (Aizenman et al., 2000b; 
McLaughlin et al., 2001; Bossy-Wetzel et al., 2004; Redman et al., 2006).  With the use of 
dominant negative mutant subunits, Kv2.1, the major component of the delayed rectifier K+ 
current in neurons (Murakoshi and Trimmer, 1999; Malin and Nerbonne, 2002),  was identified 
as the channel responsible for mediating the apoptotic K+ current surge in cortical neurons (Pal et 
al., 2003).  During oxidant-induced neuronal apoptosis, the liberation of intracellular Zn2+ from 
metal binding proteins (Aizenman et al., 2000b) leads to the activation of p38 mitogen-activated 
protein kinase (MAPK), which precedes and is necessary for the characteristic K+ current surge 
(McLaughlin et al., 2001; Bossy-Wetzel et al., 2004).  This enhancement of K+ currents is due to 
a SNARE-dependent insertion of new Kv2.1-encoded channels (Pal et al., 2006), rather than an 
alteration in the properties of existing surface channels, such as a change in activation kinetics 
(Yu et al., 1997). In spite of this information, the molecular process connecting p38 activation 
and the apoptotic membrane insertion of Kv2.1 K+ channels had heretofore remained undefined.   
 
 Here, we combine several experimental approaches to establish a direct link between 
active p38 and Kv2.1 during apoptosis after a sequence-based prediction model (Obenauer et al., 
2003) was used to identify a putative phosphorylation site for the MAPK on the C-terminal of 
 29 
the channel.  First, alanine substitution of serine 800 (S800) in Kv2.1 completely abolished the 
apoptotic enhancement of K+ currents.  Second, a cysteine-containing mutant of Kv2.1 and a 
thiol-reactive covalent inhibitor were used to demonstrate that S800 is critical for membrane 
insertion of the channel during apoptosis.  Third, expression of phospho-mimetic mutant 
channels resulted in significant increases in basal K+ current densities.  Fourth, a phospho-
specific antibody directed at S800 detected a p38-dependent increase in phospho-Kv2.1 levels in 
apoptotic neurons, and revealed phosphorylation of immunopurified Kv2.1, but not of 
Kv2.1(S800A), incubated with active p38.  Most significantly, Kv2.1(S800A) did not support 
apoptosis mediated by the wild-type channel in a recombinant expression system.   This study 
establishes that p38-mediated phosphorylation of Kv2.1 is necessary and sufficient for its 
apoptotic trafficking and completion of the cell death program. 
 
2.3  Materials and Methods 
 
Plasmids and site-directed mutagenesis.  The mammalian expression vector 
encoding wild-type Kv2.1 was the gift of J. Trimmer (UC Davis).  The poly-myc tagged Kv2.1 
plasmid was from K. Takimoto (U. Pittsburgh).  The FLAG tagged dominant negative 
Kv2.1(W365, Y380T) plasmid was provided by J. Nerbonne (Wash U., St. Louis).  S. Korn 
(NIH/NINDS) provided the Kv2.1(I379C) vector.  Mutagenesis of these cDNAs was performed 
using the QuickChange XL kit (Stratagene, La Jolla, CA) according to manufacturer’s directions.  
Primers containing the desired mutations (S800A, S800D, S800E) were obtained from Integrated 
DNA Technologies (Coralville, IA).  Mutations were confirmed by sequencing.  A plasmid 
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encoding enhanced green fluorescent protein (pCMVIE-eGFP; Clontech, Palo Alto, CA) was 
used for the identification of positively transfected cells.         
 
Tissue culture.  Chinese hamster ovary (CHO) cells were plated at a density of 
5.6 x 104 cells per well on coverslips in 24 well plates 24 hr prior to transfection.  Cells were 
treated for 4 hr in serum free medium (F12 nutrient medium with 10 mM HEPES) with a total of 
1.2 µl Lipofectamine (Invitrogen, Carlsbad, CA) and 0.28 µg DNA per well (0.14 µg of both 
eGFP and potassium channel cDNA).  Cells were briefly washed in Minimal Essential Medium 
with Earle’s salts containing 25 mM HEPES and 0.01% bovine serum albumin (MHB).  
Following transfection, cells were maintained in F12 medium containing fetal bovine serum 
(FBS) at 37°C, 5% CO2 for 48 hr prior to recordings.  
  
  Cortical neurons were prepared from embryonic day 16 rat embryos and grown in 
6-well plates according to (McLaughlin et al., 2001).  Cultures were exposed to drug treatment 
procedures at 25-29 d in vitro.  Cells were briefly washed in MHB and maintained in D2C 
growth medium until harvesting.  Cells were harvested 3hr post-treatment in lysis buffer (1% 
Triton X-100, 0.1% SDS, 0.25% Na deoxycholate, 50 mM HEPES, 150 mM NaCl, protease 
inhibitor cocktail (Roche diagnostics), pH 7.5) after two washes with PBS.  Cell lysate samples 
were combined in a 1:1 ratio with reducing sample prep buffer and incubated for 5 min at 100ºC 
in order to denature proteins prior to gel electrophoresis. 
 
Drug treatment.   The apoptotic stimulus for the electrophysiological 
experiments in CHO cells consisted of a 5 min treatment with 25 µM DTDP at 37°C, 5% CO2.  
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The DTDP containing solution was then removed and replaced with fresh F12 medium 
containing 10 µM 1-3-boc-aspartyl (Ome)-fluoromethyl-ketone (BAF), a broad-spectrum 
cysteine protease inhibitor.  BAF was necessary to maintain cells viable for electrophysiological 
recordings since Kv2.1-expressing cells are highly susceptible to DTDP-induced apoptosis (Pal 
et al., 2003).  Cells were subsequently maintained in BAF containing medium and 
electrophysiological recordings were performed approximately 3 hr following oxidative injury.  
For channel insertion experiments, cells were first treated with 4 µM of the  membrane 
impermeant thiol reagent (2-trimethylammoniumethyl) methanethiosulfate (MTSET) (Zhang et 
al., 1996; Sun et al., 2004) for 10 min to covalently block all Kv2.1(I379C) or Kv2.1(I379C, 
S800A) channels present on the plasma membrane surface prior to the usual DTDP exposure 
(Pal et al., 2006).  The apoptotic stimulus for the biochemical experiments on rat primary cortical 
neurons consisted of a 10 min treatment with 100 µM DTDP at 37ºC, 5% CO2 (Aizenman et al., 
2000b; McLaughlin et al., 2001).  Cortical neurons were pre-treated with either vehicle or the 
specific p38 MAPK inhibitor SB-293063 (SB; 20 µM for 10 min). 
 
Electrophysiological measurements.  Current recordings were performed on 
eGFP positive cells using the whole-cell patch clamp configuration technique, as described 
previously (McLaughlin et al., 2001).  We observed that 97% of GFP-positive CHO cells co-
transfected with Kv2.1 had measurable K+ currents.  The intracellular electrode solution 
contained (in mM): 100 K-gluconate, 10 KCl, 1 MgCl2, 1 CaCl2 x 2H2O, 10 HEPES; pH 
adjusted to 7.2 with concentrated KOH; 0.22 mM ATP was added and the osmolarity was 
adjusted to 280 mOsm with sucrose.  The extracellular solution contained (in mM): 115 NaCl, 
2.5 KCl, 2.0 MgCl2, 10 HEPES, 0.1 BAPTA, 10 D-glucose, 0.1 tetrodotoxin; pH was adjusted to 
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7.2.  Measurements were obtained under voltage clamp conditions with an Axopatch 1-D 
amplifier (Axon Instruments, Foster City, CA) and pClamp software (Axon instruments) using 2-
3 MΩ electrodes.  Recording electrodes were pulled from 1.5 mm borosilicate glass (Warner 
Instruments, Hamden, CT) with a model P-97 mechanical pipette puller (Sutter Instruments, 
Novato, CA).  Series resistance was partially compensated (80%) in all cases.  Currents were 
filtered at 2 kHz and digitized at 10 kHz with Digidata (Axon Instruments) software.  Potassium 
currents were evoked with incremental 15 mV voltage steps to +35 from a holding potential of –
70 mV.  To determine current density values, steady-state current amplitudes were measured at 
80 msec after the initiation of the + 5 mV step and normalized to cell capacitance.  All data are 
expressed as mean ± S.E.M. and statistical analysis was performed using InStat software 
(GraphPad, San Diego, CA).   
 
Generation of phospho-specific antibody.  To generate an antibody specific for 
the phosphorylated p38 MAP kinase consensus sequence of Kv2.1 (pKv2.1; Supporting Fig. 2), 
we synthesized the peptide C-KNHFESSPLPTS(p)PKFLR (Tufts University Core Facility, 
Boston, MA).  The high-pressure liquid chromatography purified peptide was conjugated to 
keyhole limpet hemocyanin (Pierce Chemical Co., Rockford, Illinois) with Sulfo-Link (44895; 
Pierce) following the manufacturer’s protocol.  Antiserum was generated in New Zealand white 
rabbits at Covance (Princeton, New Jersey).  Following pre-bleed screening, animals were 
initially injected with 1.5 mg immunogen, followed by 3 monthly boosts of 0.75 mg and 3 
monthly boosts of 0.5 mg.  The crude serum was affinity purified using an Immunopure (A) IgG 
Purification Kit (Pierce) according to the methods described by the manufacturer, and the 
resulting product was used in the experiments reported here. A commercially available Kv2.1 
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polyclonal antibody (Alomone Labs, Jerusalem, Israel), which was not targeted to the p38 site, 
was used as a control in immunoblots. 
 
Cell-free kinase assay.   Poly-myc-Kv2.1 and poly-myc-Kv2.1(S800A) 
expressed protein from transfected CHO cells were immunoprecipitated by incubating cell 
lysates with an anti-myc-tag rabbit polyclonal antibody (40 µg/µl) (MBL International Corp., 
Woburn, MA) followed by protein A/G PLUS-Agarose immunoprecipitation reagent (Santa 
Cruz Biotechnology Inc., Santa Cruz, CA).  The immunopurified substrate was incubated in 15 
µl of kinase buffer (in mM: 25 HEPES, pH 8.0, 2 DTT and 0.1 vanadate), 15 µl of Mg/ATP (50 
mM MgCl and 50 µM ATP) and 50 µg activated p38α ( (Roche Protein Expression Group, 
Indianapolis, IN) for 1hr at 30˚C.  Reactions containing kinase buffer alone and kinase buffer + 
Mg/ATP were used as controls.  The reaction was stopped with sample preparation buffer (625 
mM Tris, 25% glycerol, 2% SDS, 0.01% bromophenol blue and 5% β-mercaptoethanol) and 
incubated at 100°C for 5 min prior to SDS-PAGE and immunoblotting.  Immunoblotting was 
performed with the pKv2.1 antibody (1:12,000) and with a commercially available polyclonal 
Kv2.1 antibody (1:3000) (Alomone Labs, Jerusalem, Israel).   
 
Electrophoresis and immunoblotting.   Sodium dodecyl sulphate–
polyacrylamide gel electrophoresis was carried out by standard procedures using the Mini 
Protean 3 System (Bio-Rad, Hercules, CA).  Equal amounts of cell lysate were separated by 
reducing 6% or 10% SDS-PAGE gels.  Separated protein bands were transferred onto a 0.2 µm 
nitrocellulose membrane (Bio-Rad).  The membranes were then blocked with 1% Bovine Serum 
Albumin (BSA) in PBS with 0.05% Tween 20 (PBST) at room temperature for 1 hr, and probed 
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with appropriate primary antibodies diluted in PBST.  Blots were then incubated with goat 
secondary antibody conjugated to horseradish peroxidase at room temperature for 1 hr.  Blots 
were visualized using SuperSignal CL-HRP Substrate System (Pierce, Rockford, IL) and 
exposed to BioMax films (Kodak, CT).  In the cortical culture experiments, optical density 
measurements (Scion Image software, NIH) were taken of both pKv2.1 immunoreactive bands, 
normalized to their respective Kv2.1 immunoreactive bands and the resulting values were 
pooled.   
 
Viability Assays.  Chinese hamster ovary (CHO) cells were plated and 
transfected with eGFP and pRBG4 vector plus Kv2.1, Kv2.1(S800A) or Kv2.1(W365C/Y380T) 
according to the protocol described above, with 0.28 µg DNA added per well (0.14 µg:0.13 µg: 
0.0028 µg; eGFP: empty vector: potassium channel cDNA).  Twenty-four hr following 
transfection, cells were exposed to either 30 µM DTDP or vehicle for 15 min at 37ºC, 5%CO2.  
Twenty-four hr following treatment, counts of GFP positive cells were obtained by a person 
blinded to the experimental treatment groups from 15 fields with a 20X objective per coverslip; 3 
coverslips were counted per condition in 3 independent experiments. 
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2.4  Results 
 
2.4.1  S800 in Kv2.1 is necessary for the apoptotic surge in K+ currents.   
Scansite (http://scansite.mit.edu), a program that predicts protein phosphorylation sites 
based on proteomic and biochemical data (Obenauer et al., 2003), was utilized to search for 
potential MAPK targets in Kv2.1 (GenBank NM_013186).  A medium-stringency scan revealed 
a single serine residue at position 800 (Fig. 2a) as a potential phosphorylation target for both p38 
and extracellular signal regulated kinase (ERK).  However, the Scansite score for this sequence 
suggested a substantially better match for p38 than for ERK.  S800 resides in the serine and 
threonine-rich intracellular C-terminal tail of the protein (Fig. 2a), where other phosphorylation 
sites exist (Park et al., 2006).  We thus examined the role of S800 in the up-regulation of K+ 
currents during oxidant-induced apoptosis in a recombinant expression system.  
 
Whole-cell electrophysiological recordings were performed on Chinese Hamster Ovary 
(CHO) cells transiently expressing either wild-type Kv2.1 channels or a non-phosphorylatable 
mutant, Kv2.1(S800A).  CHO cells have no endogenous voltage-gated K+ channels (Yu and 
Kerchner, 1998), but can be induced to readily undergo oxidant-induced apoptosis after 
expressing Kv2.1 (Pal et al., 2003), and, like neurons, show a pronounced K+ current 
enhancement during this process (Pal et al., 2006).  Recordings were obtained under control 
conditions and following treatment with the oxidant apoptogen 2,2’-dithiodipyridine (DTDP; 
(Aizenman et al., 2000b; Pal et al., 2006).  Electrophysiological measurements were routinely 
performed 3 hours following oxidant exposure, a time when a robust K+ current surge is well 
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established (McLaughlin et al., 2001; Pal et al., 2003; Pal et al., 2006).  As shown previously 
(Pal et al., 2006), currents mediated by wild-type Kv2.1-encoded channels were substantially 
enhanced following the apoptotic stimulus (Fig. 2b, left).  In contrast, no current surge was 
observed in CHO cells expressing Kv2.1(S800A) following the oxidant treatment (Fig. 2b, 
right), indicating that S800, a putative target for p38-mediated phosphorylation, is required for 
the increase in K+ currents during apoptosis.   
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Figure 2.  Serine 800 of Kv2.1 is critical for apoptosis associated K+ current enhancement.  (a) 
Schematic of Kv2.1 showing the putative p38 phosphorylation site on the cytoplasmic C-
terminus. (b) Top left:  Representative whole-cell K+ currents from Kv2.1-expressing CHO cells 
recorded under control and DTDP treatment conditions.  Currents were obtained 48 hr post 
transfection and evoked by sequential 15 mV voltage steps to +35 mV from a holding potential 
of  –70 mV.  Calibration: 5 nA, 15 msec.  Bottom left:  Mean ± s.e.m. K+ current densities from 
Kv2.1-expressing CHO cells under control (n = 25) and DTDP (n = 12) treatment conditions (* 
p<0.05; t test).  Currents were induced with a voltage step to +5 mV from a holding potential of 
–70 mV and normalized to cell capacitance.  Top right:  Representative whole cell K+ currents 
from Kv2.1(S800A) expressing CHO cells recorded under control and DTDP treatment 
conditions.  Bottom right:  Mean ± s.e.m. K+ current densities from Kv2.1(S800A)-expressing 
CHO cells recorded under control (n = 24) and DTDP (n = 24) treatment conditions.   
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2.4.2  S800 is required for apoptogen-induced membrane insertion of Kv2.1. 
The apoptotic surge in K+ current observed in both cortical neurons and CHO cells is the 
result of trafficking and SNARE-dependent exocytotic insertion of new Kv2.1 channels into the 
plasma membrane (Pal et al., 2006).  New channel membrane insertion was detected by utilizing 
the cysteine-containing K+ channel mutant Kv2.1(I379C) (Kurz et al., 1995).  The presence of 
this mutation allows the channel to be functionally blocked by the membrane impermeant thiol 
reagent (2-trimethylammoniumethyl) methanethiosulfate (MTSET) (Zhang et al., 1996; Sun et 
al., 2004).  Virtually all previously existing surface Kv2.1(I379C) channels can therefore be 
silenced following a 5-10 min exposure to MTSET.  With existing plasma membrane Kv2.1 
channels permanently blocked, the insertion of new channels is easily detected 
electrophysiologically by the appearance of new currents under MTSET-free conditions (Pal et 
al., 2006).  This assay, which has the distinct advantage of detecting the insertion of new 
functional channels, has been previously validated by parallel biotinylation studies (Pal et al., 
2006).      
 
In order to investigate the role of S800 in the apoptotic insertion of new channels, the 
double mutant Kv2.1(I379C, S800A) was generated.  Whole-cell recordings first confirmed the 
preservation of functional silencing by MTSET in this double mutant channel (Fig. 3a).   Next, 
CHO cells expressing either Kv2.1(I379C) or Kv2.1(I379C,S800A) were exposed to MTSET for 
10 min to block all existing surface channels.  The cells were then exposed to oxidant to trigger 
the apoptotic cascade.  Electrophysiological recordings 3 hours later revealed the presence of K+ 
currents in Kv2.1(I379C)-expressing cells (Fig. 3b), similar to what was reported earlier (Pal et 
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al., 2006).  However, little or no current could be measured in CHO cells expressing 
Kv2.1(I379C,S800A), indicating a lack of apoptotic membrane insertion of these mutant 
channels (Fig. 3b).  This result not only accounts for the lack of Kv2.1(S800A)-mediated 
apoptotic current surge observed earlier, but demonstrates that phosphorylation of S800 is 
necessary for Kv2.1 membrane insertion during the cell death program. 
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Figure 3.   S800A mutation blocks apoptogen induced membrane insertion of Kv2.1. (a) 
MTSET blocks Kv2.1(I379C) channel containing the Kv2.1(S800A) mutation. Calibration: 2nA, 
10msec.  (b) Top: Diagram representing the experimental protocol designed to measure the 
appearance of new K+ channels during the apoptotic process. Shown are representative whole-
cell K+ currents obtained from Kv2.1(I379C) and Kv2.1(I379C,S800A) expressing CHO cells 3 
hr after sequential treatment with MTSET and DTDP.  Currents were evoked by sequential 15 
mV voltage steps to +35 mV from a holding potential of  –70 mV.  Calibration: 1nA, 10msec.  
Bottom: Mean ± s.e.m. K+ current densities recorded from Kv2.1(I379C) (n=17) and 
Kv2.1(I379C, S800A) (n=20) expressing CHO cells 3 hr after the sequential MTSET/DTDP 
treatments (*p<0.01; t test).  These currents represent the newly inserted channels during 
apoptosis 
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2.4.3  Negatively charged amino acids at position 800 mimic the apoptotic 
surge.  Recordings were performed from CHO cells transiently expressing two additional 
variants of Kv2.1 to test whether substitution of S800 with negatively charged residues would 
mimic the apoptotic increase in currents observed in wild-type channels.  Indeed, basal current 
densities in untreated Kv2.1(S800D) and Kv2.1(S800E) mutant expressing cells displayed 
significantly enhanced amplitudes, comparable to those observed in DTDP-treated Kv2.1-
expressing cells (Fig. 4).  Oxidant treatment of cells expressing these mutations did not produce 
any additional current enhancement (not shown).  Rather, a slight decrease in the currents was 
observed under these conditions, likely the result of cellular damage by the injurious stimulus.   
These results further support the role of S800 phosphorylation as a key mediator of the K+ 
current surge during apoptosis. 
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Figure 4.  Substitution of serine 800 with negatively charged amino acids mimics apoptotic K+ 
current densities.  Top: Representative whole-cell K+ currents from Kv2.1, Kv2.1(S800D) and 
Kv2.1(S800E) expressing CHO cells.  Currents were obtained 48 hr post transfection and evoked 
by sequential 15 mV voltage steps to +35 mV from a holding potential of  –70 mV.  Calibration: 
5 nA, 15 msec.  Bottom:  Mean ± s.e.m. current densities from Kv2.1 (n=13), Kv2.1(S800D) (n 
= 17) and Kv2.1 (S800E) (n=14) expressing CHO cells; (*p<0.05; t test).   
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2.4.4 S800 phosphorylation is p38-dependent in neurons undergoing 
apoptosis.  Biochemical studies were performed to detect phospho-S800 levels in primary 
cortical neurons following oxidative injury.  Cell lysates were subjected to gel electrophoresis 
and the resulting blots were probed with a commercially available antibody directed against 
amino acids 841-857 of the C-terminus of Kv2.1 (Kv2.1; Alomone Labs, Jerusalem, Israel) or 
with an antibody that we generated against the phosphorylated form of S800 (pKv2.1; 
Supplemetary Fig. 1).  Immunoblots probed with Kv2.1-directed antibodies revealed the 
presence of two major bands in cortical extracts: a diffuse band near 100 kDa and another, more 
compact band, at approximately 80 kDa (Supplementary Fig. 1; see also (Trimmer, 1993; 
Scannevin et al., 1996; Chung and Li, 2005).  The diffuse band near 100 kDa likely represents 
multiple, non-p38 dependent phosphorylation states of the predicted full-length channel 
(Misonou et al., 2004; Park et al., 2006), while the 80 kDa band may reflect the presence of a 
protein generated by an alternative mRNA isoform (Trimmer, 1993; Roder and Koren, 2006) or 
a proteolytic fragment.  Importantly, preincubation of the two antibodies with their respective 
immunizing peptides completely blocked both immunoreactive signals (Supplementary Fig. 2).      
 
Phospho-S800 levels in cortical neuronal lysates were assessed using the pKv2.1 
antibody under control conditions and following oxidative injury.  We observed a significant 
increase in pKv2.1 immunoreactivity in cortical neurons undergoing apoptosis, compared to 
vehicle-treated controls (Fig. 5A,B).  This was particularly apparent in the compact, 80 kDa 
band.   Importantly, SB-239063, a selective p38 inhibitor (Barone et al., 2001; McLaughlin et al., 
2001) prevented oxidant-mediated increases in pKv2.1 immunoreactivity (Fig. 5A,B).  These 
 47 
data confirm a p38-dependent increase in phospho-S800 levels in endogenous Kv2.1 channels 
from cortical neurons undergoing apoptosis. 
 
2.4.5  Active p38 phosphorylates S800 in cell free assays.  To determine 
whether p38 could phosphorylate Kv2.1, we performed a cell-free assay in which recombinantly-
expressed, immunoprecipitated poly myc-tagged wild-type Kv2.1 (myc-Kv2.1; (Ren et al., 2003; 
Pal et al., 2006) was used as a substrate for purified, active p38.  We observed that myc-Kv2.1 
protein exposed to active p38 produced a phospho-specific immunoreactive band (Fig. 5C).    
Similar experiments performed with an S800A mutant of the myc-tagged Kv2.1 yielded no 
phospho-specific signal (Fig. 5C).  These results indicate that active p38 can directly induce 
selective phosphorylation of residue S800 of Kv2.1. 
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Figure 5. A, DTDP-induced phosphorylation of Kv2.1-S800 is regulated by p38 MAPK in 
cultured cortical neurons.  (Experiments completed by Kai He, Ph.D.)  Cortical cultures were 
pre-treated with either vehicle or the specific p38 MAPK inhibitor SB293063 (SB; 20 µM for 10 
min) and then incubated with either vehicle or DTDP (100 µM for 10 min).  Immunoblots were 
probed with anti-pKv2.1 antibody (1:5000; top), a commercially available anti-Kv2.1 antibody 
(Alomone Labs, Jerusalem, Israel, 1:1000; middle) and an anti-GAPDH antibody (Novus 
Biologicals, Littleton, CO, 1:5000; bottom) to confirm equal protein loading between lanes.  
These data are representative of results from 3 independent experiments.  B, Oxidative injury 
significantly increases S800 phosphorylation in cortical neurons in vitro. (Experiments 
completed by Kai He, Ph.D.)   Optical density measurements of the phosphorylation level and its 
protein loading control at both the 100kDa and the 80 kDa band were quantified using Scion 
Image software. Values represent the mean ± s.e.m. normalized pKv2.1 signal (to Kv2.1 
immunoreactivity) of both bands as a percentage of vehicle-treated control from 3 separate, 
independent experiments (*p<0.01; ANOVA/Dunnett).  Note that the observed increase in S800 
phosphorylation was effectively blocked with a p38 MAPK inhibitor.  C, Serine 800 of Kv2.1 is 
phosphorylated by p38α in a cell-free kinase assay.  Myc-Kv2.1 and Myc-Kv2.1(S800A) 
proteins were immunoprecipitated (IP) from CHO cell lysates and reacted at 30°C for 1hr with 
15 µL of kinase buffer (in mM: 25 HEPES, pH 8.0, 2 DTT and 0.1 vanadate), 15 µL of Mg/ATP 
(50 mM MgCl and 50 µM ATP) and 50 µg activated p38α kinase.  Reactions containing kinase 
buffer and Mg/ATP and kinase buffer alone were used as controls.  Immunoblots (IB) were 
probed with the pKv2.1 antibody (1:12,000) and with the Kv2.1 antibody (1:3000; Alomone).   
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2.4.6  S800A mutation disrupts Kv2.1-mediated apoptosis.  Unlike truncated or 
pore mutants of the channel (Pal et al., 2003), Kv2.1(S800A) does not function as a dominant 
interfering form in neurons undergoing apoptosis, but simply enhances the overall basal current 
amplitude without eliminating the contribution of endogenous channels (not shown).  As such, 
the requirement for S800 phosphorylation in apoptosis was evaluated in Kv2.1-expressing CHO 
cells under oxidant exposure conditions that are normally sub-lethal to vector-expressing control 
cells (Pal et al., 2003).  A 15 min exposure to 30 µM DTDP was sufficient to induce apoptosis in 
approximately 50% of wild-type Kv2.1 expressing cells (Fig. 6).  However, the same oxidative 
insult was completely innocuous to CHO cells expressing Kv2.1(S800A) mutant channels.  As a 
negative control, we assayed the viability of CHO cells expressing a non-conducting, double-
pore mutant Kv2.1(W365C, Y380T) channel (Malin and Nerbonne, 2002).  Similar to cells 
expressing Kv2.1(S800A), the oxidant was not toxic to cells expressing the double-pore mutant 
channels.  These data demonstrate the requirement for functional Kv2.1 channels containing the 
phosphorylatable amino acid residue S800 to complete the apoptotic program. 
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Figure 6.  S800A mutation blocks Kv2.1-mediated apoptosis.  CHO cells were co-transfected 
with eGFP + pRBG4 vector and either Kv2.1, Kv2.1(S800A) or non-conducting Kv2.1(W365C, 
Y380T) and 24 hr later exposed to 30 µM DTDP (15 min).  Viability was assayed 24 hr post-
treatment by counting GFP positive cells and expressed as a percent of vehicle-treated control.  
Note that DTDP induced approximately 50% cell death in Kv2.1 expressing CHO cells but was 
not lethal to either Kv2.1(S800A) or Kv2.1(W365C, Y380T) expressing CHO cells.  Values 
represent the mean ± s.e.m. viability from 3 separate, independent experiments (*p<0.05; 
ANOVA/Dunnett). 
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2.5  Discussion 
 
The results presented in this study reveal an important and previously unrecognized 
mechanism of Kv2.1 regulation that has a critical impact on apoptosis.  Kv2.1 is subject to 
extensive phosphorylation and dephosphorylation reactions, which alter the functional properties 
of this channel by influencing gating, and thereby, cell firing properties (Du et al., 2000; Park et 
al., 2006).  We have found, however, a phosphorylation target for p38 on the C-terminal of 
Kv2.1 that is vital for the apoptotic surge of K+ currents observed in apoptosis, as well as for 
completion of the cell death program.  Interestingly, a paper by (Park et al., 2006) reported that 
S800 is a phosphorylation target, albeit by a then unidentified kinase.  These authors further 
showed that S800 was not one of the several C-terminal sites subject to calcineurin-dependent 
dephosphorylation and did not participate in the graded regulation of Kv2.1 gating.  We have 
found here that S800 is a unique p38 phosphorylation target on Kv2.1 that is required for channel 
trafficking and cell death.   
 
Phosphorylation of S800 is not necessary, in and of itself, for normal Kv2.1 trafficking 
and plasma membrane insertion, as Kv2.1(S800A) mutant channels can be functionally 
expressed.  Indeed, normal neurons overexpressing this construct simply have larger K+ currents, 
which explains why this mutated form of Kv2.1 cannot function as a dominant interfering 
channel during neuronal apoptosis.  Nonetheless, our studies in CHO cells reveal that under 
injurious situations this site is critical for de novo channel insertion, resulting in the current surge 
necessary for cytoplasmic K+ loss and cell death.     
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Earlier studies revealed that the Kv2.1-mediated current surge during apoptosis is a result 
of the insertion of new channels into the plasma membrane (Pal et al., 2006), and the p38 MAPK 
signaling pathway is instrumental in this process (McLaughlin et al., 2001; Bossy-Wetzel et al., 
2004; Pal et al., 2004).  Interestingly, p38 activation by tumor necrosis factor α has also been 
implicated in the potentiation of tetrodotoxin-resistant Na+ currents in sensory neurons, although 
a direct phosphorylation of the channel by p38 has not been documented (Jin and Gereau, 2006). 
The MAPK can phosphorylate Nav1.6 encoded Na+ channels, but in this case the resulting 
interaction produces a decrease, rather than an increase, in Na+ currents (Wittmack et al., 2005). 
In addition, another member of the MAPK family, ERK1/2, phosphorylates Kv4.2, a potassium 
channel responsible for A-type K+ currents in neurons (Adams et al., 2000; Schrader et al., 
2006),  resulting in a downregulation of dendritic K+ currents in CA1 hippocampal pyramidal 
neurons (Yuan et al., 2002).   Collectively, this information indicates that MAPKs participate in 
cell signaling events that alter the contribution of voltage-gated ion channels to overall neuronal 
excitability.  Our results demonstrate that p38 phosphorylation of Kv2.1 is required for an 
entirely different, but critical process: completion of the apoptotic program. 
 
Several issues remain to be addressed.  Primarily among them, the molecular mechanism 
linking p38-induced phosphorylation of Kv2.1 to the membrane insertion of this channel remains 
to be determined.  We previously observed that cleavage and inactivation of the exocytotic 
SNARE proteins SNAP-25 and syntaxin was sufficient to prevent the apoptotic K+ current surge 
(Pal et al., 2006).  Importantly, both these proteins are known to directly interact with 
Kv2.1(Michaelevski et al., 2003): SNAP-25 with the cytoplasmic N-terminal (MacDonald et al., 
2002), and syntaxin with two domains of the cytoplasmic C-terminal tail (Leung et al., 2003). 
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Overexpression of syntaxin and Kv2.1 inhibits channel surfacing and leads to a decrease in 
Kv2.1-mediated current density (Leung et al., 2003).  It is thus tempting to speculate that p38 
phosphorylation of Kv2.1 leads to changes in its association with syntaxin or other proteins, 
promoting, in turn, exocytosis of channel containing vesicles.  In addition, Kv2.1 subunits 
consistently co-localize with cortical neuron subsurface cisterns, compressed stacks of smooth 
endoplasmic reticulum situated approximately 5-8 nm beneath the plasma membrane (Du et al., 
1998).  Thus, the possibility exists for cisternae to serve as a nearby holding area for channels 
destined for the plasma membrane (O'Connell and Tamkun, 2005), with p38 phosphorylation 
serving as the molecular switch necessary to free Kv2.1 from cisternal retention during 
apoptosis.   
 
In summary, we have identified a putative p38 phosphorylation target residue on the C-
terminal of Kv2.1.  Importantly, mutation of S800 to a non-phosphorylatable residue is sufficient 
to disrupt the apoptotic cascade initiated by oxidative injury and block cell death.  The work 
described here illustrates a critical mechanistic link between oxidant-induced Zn2+ release 
(Aizenman et al., 2000), p38 MAPK activation (McLaughlin et al., 2001; Bossy-Wetzel et al., 
2004), the ensuing Kv2.1-mediated apoptotic K+ current surge (Pal et al., 2003; Pal et al., 2006), 
and cell death.  Thus, prevention of Kv2.1 phosphorylation by p38 is a potential novel 
therapeutic target for promoting neuronal survival during injurious oxidative stress conditions. 
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3.  A Zn2+-dependent dual phosphorylation checkpoint regulates the apoptotic surge of K+ 
currents. 
 
3.1  Abstract 
  
Oxidant-liberated intracellular Zn2+ regulates neuronal apoptosis via an exocytotic 
membrane insertion of Kv2.1-encoded ion channels, resulting in a requisite enhancement of 
voltage-gated K+ currents.  In the present study, we show that an N-terminal tyrosine of Kv2.1 
(Y124), which is targeted by src, is critical for the apoptotic current surge.  Moreover, Y124 
works in concert with a C-terminal serine (S800) target of p38 MAPK to regulate Kv2.1-
mediated current enhancement.  While Zn2+ was previously shown to activate p38, we 
demonstrate here that this metal inhibits cytoplasmic protein tyrosine phosphatase ε (Cyt-PTPε), 
which specifically targets Y124 and antagonizes the actions of src.  Importantly, disruption of 
Y124 phosphorylation by a point mutation or by Cyt-PTPε over-expression protects cells from 
injury.  Therefore, a dual tyrosine-serine phosphorylation checkpoint on Kv2.1 regulates 
neuronal survival by providing a converging input for two Zn2+-dependent signal transduction 
cascades. 
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 3.2  Introduction   
   
K+ efflux mediated by a surge of voltage-gated K+ channel activity is a necessary 
component of neuronal apoptosis (Yu, 2003a).  This current enhancement leads to reduced 
cytoplasmic K+ concentrations (Yu et al., 1999), a permissive pro-apoptotic environment 
(Bortner and Cidlowski, 1999, 2007) as the catalytic activity of both caspases and apoptotic 
nucleases increases at low ionic strength (Hughes and Cidlowski, 1999).  This effect is 
significant because inhibiting K+ efflux effectively attenuates apoptotic cell death (Yu et al., 
1997; Yu et al., 1998; Yu et al., 1999; Aizenman et al., 2000b; McLaughlin et al., 2001; Bossy-
Wetzel et al., 2004). 
   
Kv2.1, the primary delayed rectifying potassium channel in neurons (Murakoshi and 
Trimmer, 1999; Malin and Nerbonne, 2002), is the main channel responsible for the apoptotic K+ 
current surge in rat cortical neurons (Pal et al., 2003).  Following injury, the liberation of 
intracellular Zn2+ from metal binding proteins (Aizenman et al., 2000a) facilitates the generation 
of signaling reactive oxygen species (ROS) (Sensi and Jeng, 2004; Zhang et al., 2004) leading to 
the activation of p38 mitogen-activated protein kinase (MAPK) via the upstream kinase ASK-1 
(McLaughlin et al., 2001; Aras and Aizenman, 2005).  The subsequent enhancement of K+ 
currents following Zn2+-dependent p38 activation is mediated by the soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE)-dependent exocytotic plasma membrane 
insertion of new Kv2.1 channels (Pal et al., 2003; Pal et al., 2006; Redman et al., 2007).   The 
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surface delivery of Kv2.1 during apoptosis requires the phosphorylation of intracellular C-
terminal residue serine 800 (S800) by p38 MAPK (Redman et al., 2007).   
  
Kv2.1-mediated K+ currents can also be amplified during non-injurious conditions 
through direct phosphorylation of intracellular N-terminal residue tyrosine 124 (Y124) by src 
(Tiran et al., 2003; Tiran et al., 2006).   Since elevations in cytoplasmic Zn2+, linked to cell injury 
(Paul et al., 2001; Lennmyr et al., 2004), have been shown to activate src (Wu et al., 2002; 
Huang et al., 2008), we sought to investigate the requirement of converging src and p38 
(Redman et al., 2007) phosphorylation events on apoptotic Kv2.1 trafficking and neuronal 
viability.  We hypothesized that both intracellular termini contribute to the apoptotic K+ current 
surge, as an interaction between these domains is required for channel surface delivery under 
normal conditions (Mohapatra et al., 2008).  In addition, exocytotic SNARE proteins physically 
associate with the N- and C- terminal (MacDonald et al., 2002; Leung et al., 2003; Tsuk et al., 
2005; Lvov et al., 2008; Tsuk et al., 2008), and SNARE cleavage blocks channel surface delivery 
during apoptosis (Pal et al., 2006).  Results presented here demonstrate that Y124 on Kv2.1 is 
essential for the apoptotic surge of K+ currents.  In addition, disruption of Y124 phosphorylation 
strongly influences cell viability by modulating the effects of S800 on the current enhancement 
in a Zn2+-dependent fashion. 
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3.3 Materials and Methods 
 
Plasmids and site-directed mutagenesis.  The mammalian expression vector 
encoding wild-type Kv2.1 was the gift of J. Trimmer (UC Davis). The Kv2.1(Y124F), Cyt-PTPε 
and Cyt-PTPε(D245A) plasmids were a gift from A. Elson (Weizmann Institute, Rehovot, 
Israel).   Mutagenesis of these cDNAs was performed using the QuickChange XL kit 
(Stratagene, La Jolla, CA) according to manufacturer’s directions.  Primers containing the 
desired mutations (Y124F, Y124D, S800D) were obtained from Integrated DNA Technologies 
(Coralville, IA).  Mutations were confirmed by sequencing.  A plasmid encoding enhanced green 
fluorescent protein (pCMVIE-eGFP; Clontech, Palo Alto, CA) was used for the visual 
identification of positively transfected cells.  We found that the Y124D mutation did not mimic 
the phosphorylation state at this site (results not shown).       
 
Tissue culture and transfection.  Chinese hamster ovary (CHO) cells were 
plated at a density of 5.6 x 104 cells per well on coverslips in 24 well plates 24 hr prior to 
transfection.  Cells were treated for 4 hr in serum free medium (F12 nutrient medium with 10 
mM HEPES) with a total of 1.2 µl Lipofectamine (Invitrogen, Carlsbad, CA) and 0.28 µg DNA 
per well (0.14 µg eGFP, 0.126 µg empty pRBG4 vector and 0.014 µg potassium channel cDNA).  
Following transfection, cells were maintained in F12 medium containing fetal bovine serum 
(FBS) at 37°C, 5% CO2 for 24 hr prior to recordings.  
  
Cortical neurons were prepared from embryonic day 16 rat embryos and grown in 6-well 
plates according to McLaughlin et al. (2001).  Cultures (18-22 d in vitro) were transfected using 
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Lipofectamine 2000 (Invitrogen, Carlsbad, CA)(Ohki et al., 2001).  Briefly, 1.5 µg of cDNA was 
diluted in 50 µl Opti-Mem medium and combined with 50 µl of Opti-Mem I medium containing 
2 µl Lipofectamine 2000 reagent.  Lipid-DNA complexes were allowed to form for 30 min at 
room temperature and then added to cortical cultures.  Cells were then maintained at 37ºC, 
5%CO2 for 24-48h before drug treatment procedures and toxicity assays. 
 
Drug treatment.   The apoptotic stimulus for the electrophysiological 
experiments in CHO cells consisted of a 5 min treatment with 30 µM DTDP at 37°C, 5% CO2. 
The DTDP containing solution was then removed and replaced with fresh F12 medium 
containing 10 µM 1-3-boc-aspartyl (Ome)-fluoromethyl-ketone (BAF), a broad-spectrum 
cysteine protease inhibitor.  BAF was necessary to maintain cells viable for electrophysiological 
recordings since Kv2.1-expressing cells are highly susceptible to DTDP-induced apoptosis (Pal 
et al., 2003).  Electrophysiological recordings were performed approximately 3 hr following 
oxidative injury.  The apoptotic stimulus for the electrophysiological experiments in cortical 
neurons consisted of a 10 min treatment with 30 µM DTDP at 37°C, 5% CO2.   The DTDP 
containing solution was then removed and replaced with conditioned growth medium containing 
10 µM BAF.  For the src inhibition experiments, either 10 µM 4-Amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine (PP2) or 10 µM of the inactive structural analog 4-Amino-7-
phenylpyrazol[3,4-d]pyrimidine (PP3) were included in the treatment solution and post-treatment 
medium.   
 
Electrophysiological measurements.  Current recordings were performed on 
eGFP positive CHO cells and cortical neurons using the whole-cell patch clamp configuration 
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technique, as described previously (McLaughlin et al., 2001).  Ninety seven percent of GFP-
positive CHO cells co-transfected with Kv2.1 had measurable K+ currents.  Ninety percent of 
GFP-positive neurons express co-transfected plasmids (Santos and Aizenman, 2002).  The 
intracellular electrode solution contained (in mM): 100 K-gluconate, 10 KCl, 1 MgCl2, 1 CaCl2 x 
2H2O, 10 HEPES; pH adjusted to 7.2 with concentrated KOH; 0.22 mM ATP was added and the 
osmolarity was adjusted to 280 mOsm with sucrose.  The extracellular solution contained (in 
mM): 115 NaCl, 2.5 KCl, 2.0 MgCl2, 10 HEPES, 0.1 BAPTA, 10 D-glucose, 0.1 tetrodotoxin; 
pH was adjusted to 7.2.  Measurements were obtained under voltage clamp conditions with an 
Axopatch 1-D amplifier (Axon Instruments, Foster City, CA) and pClamp software (Axon 
instruments) using 2-3 MΩ electrodes.  Recording electrodes were pulled from 1.5 mm 
borosilicate glass (Warner Instruments, Hamden, CT) with a model P-97 mechanical pipette 
puller (Sutter Instruments, Novato, CA).  Series resistance was partially compensated (80%) in 
all cases.  Currents were filtered at 2 kHz and digitized at 10 kHz with Digidata (Axon 
Instruments) software.  Potassium currents were evoked with incremental 10 mV voltage steps to 
+80 mV from a holding potential of –80 mV.  To determine current density values, steady-state 
current amplitudes were measured at 180 msec after the initiation of the -80 mV to +10 mV step 
and normalized to cell capacitance.  All data are expressed as mean ± S.E.M. and statistical 
analyses were performed using InStat software (GraphPad, San Diego, CA).   
 
Phosphatase Assay.  CHO cells were lysed in buffer A (50mM Tris-HCl pH 7.5, 
100mM NaCl, 1% NP-40) (Tiran et al., 2006) containing protease inhibitors (Complete Mini 
protease inhibitor cocktail, Roche Applied Science, Indianapolis, IN).  FLAG-Cyt-PTPε 
expressed protein from transfected CHO cells was immunoprecipitated by incubating cell lysates 
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with an anti-FLAG rabbit polyclonal antibody (Sigma-Aldrich Inc., Saint Louis, MO) followed 
by protein A/G PLUS-Agarose immunoprecipitation beads (Santa Cruz Biotechnology Inc., 
Santa Cruz, CA).  The immunoprecipitated complex was then washed 3 times with buffer A, two 
times in buffer B (100mM KCl, 0.5mM EDTA pH 8.2, 20mM Hepes pH 7.6, 0.4% NP-40, 20% 
Glycerol) and two times in buffer 54K (150 NaCl, 50mM Tris pH 7.9, 0.5% Triton X-100).  
FLAG-Cyt-PTPε was then eluted by incubating the beads in 2 equal volumes of elution buffer 
(50mM MES pH 7, 0.5mM DTT, 0.5 mg/ml BSA, 1 mg/mL FLAG peptide) (Sigma-Aldrich 
Inc., Saint Louis, MO) at 32º C for 3 min.  Phosphatase from each elution step was pooled.  
Protein amounts were determined by a colorimetric protein assay (Bio-Rad, Hercules, CA).  
Phosphatase activity was then measured using a standard colorimetric malachite green 
phosphatase assay (Promega Corp., Madison, WI).  Equal amounts of purified FLAG-Cyt-
PTPε  was incubated in 96-well plates with PTPε activity buffer (50mM MES pH 7, 0.5mM 
DTT, 0.5 mg/ml BSA) and two unique chemically synthesized phospho-tyrosine peptides 
(Promega Corp., Madison, WI; END(pY)INASL (Daum et al., 1993) and DADE(pY)LIPQQG 
(Zhang et al., 1993)) gently rocking at 32º C for 18 hr.  The reaction was terminated by adding 
50ul of the molybdate/additive mixture, incubated at room temp for 15 min and then optical 
density of each sample was measured at 600nm using a plate reader (1420 Victor2 V Multilabel 
Counter, Perkin Elmer Life Sciences, Boston, MA).  Activity was expressed as pmoles 
phosphate released normalized to total Cyt-PTPε protein added to the reaction.  A standard 
activity curve was always performed with known amounts of free phosphate. 
 
Viability Assays.  Chinese hamster ovary (CHO) cells were plated and 
transfected with eGFP and pRBG4 vector plus Kv2.1 or Kv2.1(Y124F) according to the protocol 
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described above, with 0.28 µg DNA added per well (0.14 µg:0.13 µg: 0.0028 µg; eGFP: empty 
vector: potassium channel cDNA; 24-well plate).  Twenty-four hr following transfection, cells 
were exposed to either 30 µM DTDP or vehicle for 15 min at 37ºC, 5%CO2.  Twenty-four hr 
following treatment, counts of GFP positive cells were obtained from 5 random fields with a 20X 
objective per coverslip; 3 coverslips were counted per condition in 3 independent experiments.   
 
Cortical neurons were prepared from embryonic day 16 rat embryos and grown in 6-well 
plates according to McLaughlin et al. (2001).  Neurons were transfected after 3 weeks in vitro 
with equal amounts of pUHC13-3 Luciferase and either pCDNA3 vector or Cyt-PTPε  plasmids 
using Lipofectamine 2000 (Boeckman and Aizenman, 1996; Pal et al., 2003).  A rat microglial 
cell line (Cheepsunthorn et al., 2001) was plated directly onto cortical neurons at a density of 
50,000 cells/well 24hr following transfection.  Microglia were stimulated with 10 U/ml 
interferon-γ  (IFN-γ, Chemicon, Temecula, CA) and 1 µg/ml lipopolysaccharide (Knoch et al., 
2008) and cells were subsequently maintained at 37ºC, 5% CO2.  Cell viability was measured 
48hr later according to (Aras et al., 2008) using a luminescence reporter gene assay system 
(Perkin-Elmer, Boston, MA). 
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3.4  Results 
 
3.4.1  Src inhibition blocks apoptotic K+ current enhancement.  We first 
examined whether src activity was required for K+ current enhancement during oxidant-induced 
neuronal injury.  Whole-cell electrophysiological measurements were obtained from cortical 
neurons following treatment with either vehicle or the oxidant apoptogen 2,2’-dithiodipyridine 
(DTDP) (Aizenman et al., 2000b; Pal et al., 2006).  Recordings were performed approximately 
3h after a 10 min DTDP (30 µM) exposure, a time when a prominent K+ current enhancement is 
detected (McLaughlin et al., 2001; Pal et al., 2003; Pal et al., 2006; Redman et al., 2007).  As 
previously demonstrated (McLaughlin et al., 2001; Pal et al., 2003; Pal et al., 2006; Redman et 
al., 2007), neurons treated with DTDP displayed significantly enhanced K+ currents compared to 
vehicle-treated controls (Fig. 7A, B).  Recordings were also obtained following treatment of 
cortical neurons with DTDP and either the selective src inhibitor PP2 (10µM) or its inactive 
structural analog PP3 (10µM).  Apoptotic K+ current enhancement was blocked in neurons co-
treated with DTDP and PP2, while the apoptotic K+ current surge remained in neurons co-treated 
with DTDP and PP3 (Fig. 7A, B).  Additionally, treatment of cortical neurons with either PP2 or 
PP3 alone had no effect on baseline current densities (Fig. 7A, B).  These results establish the 
requirement for src activity in the apoptotic neuronal K+ current surge.  Furthermore, these 
results, in combination with our previous work (McLaughlin et al., 2001; Bossy-Wetzel et al., 
2004), show that both src and p38 signaling pathways converge upon Kv2.1 to mediate the 
apoptotic K+ current enhancement. 
 65 
 
 
 66 
Figure 7.  Src inhibition blocks the apoptotic K+ current surge.  (a) Representative whole-cell 
currents from cortical neurons recorded under control, DTDP (30µM), PP2 (10µM), DTDP + 
PP2, PP3 (10µM), and DTDP + PP3 treatment conditions. Currents were obtained 3h post injury 
and evoked by sequential 10 mV voltage steps to +80 mV from a holding potential of -80 mV.  
Calibration: 5nA, 25ms (b) Mean ± SEM current densities from cortical neurons recorded under 
control (n=13), DTDP (n=14), DTDP + PP2 (n=10), PP2 (n=10), PP3 (n=10), and DTDP + PP3 
(n=10) treatment conditions. K+ currents were evoked by a single voltage step to +10mV from a 
holding potential of -80mV and normalized to cell capacitance.   (***P<0.001, *P<0.05; 
ANOVA/Bonferroni) 
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3.4.2  Y124 is critical for the apoptotic surge in K+ currents.   CHO cells 
express no endogenous voltage-gated K+ channels (Yu and Kerchner, 1998), and undergo 
apoptosis following Kv2.1 expression after a normally sub-lethal oxidative injury (Pal et al., 
2003).  As with neurons, Kv2.1-expressing CHO cells display enhanced voltage-gated K+ 
currents during the cell death program (Pal et al., 2006).  Recordings were obtained from CHO 
cells transiently expressing either wild-type Kv2.1 or phenylalanine-substituted, Kv2.1(Y124F) 
mutant channels. Phenylalanine substitution was used to preclude phosphorylation at this site.  
Under normal conditions, CHO cells expressing Kv2.1(Y124F) channels exhibited K+ current 
densities similar to CHO cells expressing wild-type Kv2.1 channels (Fig. 8A).  Following DTDP 
exposure however, the K+ current surge observed in wild-type Kv2.1-expressing cells was 
completely abrogated in cells expressing Kv2.1(Y124F) (Fig. 8B). Serine to aspartate-substituted 
Kv2.1(S800D) mutant channels have been shown to mimic the apoptotic K+ current surge (Fig. 
8C) (Redman et al., 2007).   To further examine the requirement of Y124 in K+ current 
enhancement, we obtained recordings from CHO cells expressing Kv2.1(Y124F, S800D) double 
mutant channels.  Cells expressing Kv2.1(Y124F,S800D) channels displayed significantly 
reduced current densities compared to cells expressing Kv2.1(S800D) (Fig. 8C).  Since 
phenylalanine substitution of Y124 blocks the K+ current surge, we tested whether Y124 was 
required to support apoptosis in Kv2.1-expressing CHO cells.   While DTDP treatment was 
sufficient to induce cell death in approximately 50% of wild-type Kv2.1-expressing cells, a 
significant, more than 2-fold increase in viability was observed in Kv2.1(Y124F)-expressing 
cells (Fig. 8D).  Taken together, these data indicate that an intact Y124 is required for the 
apoptotic K+ current surge and oxidant-induced cell death.  Our results show that 
phosphorylation of S800 is not sufficient for the expression of this process.  These findings also 
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suggest that under basal conditions Y124 may normally be phosphorylated by src, at least in 
CHO cells, as evident by the elevated current densities observed in uninjured Kv2.1(S800D)-
expressing cells. 
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Figure 8.  Y124 is essential for the apoptotic K+ current surge. (a) (Left) Representative whole-
cell K+ currents from wild-type Kv2.1- and Kv2.1 (Y124F)-expressing CHO cells. Currents were 
obtained 24h post-transfection and evoked by sequential 10 mV voltage steps to +80 mV from a 
holding potential of -80 mV.  Calibration: 5nA, 25ms (Right) Mean ± SEM current densities 
from wild-type Kv2.1-expressing (n=15) and Kv2.1 (Y124F)-expressing CHO cells (n=10). (b) 
(Left) Representative whole-cell K+ currents from wild-type Kv2.1- and Kv2.1(Y124F)-
expressing CHO cells treated with DTDP. Calibration: 5nA, 25ms.  (Right) Mean ± SEM current 
densities from wild-type Kv2.1- (n=12) and Kv2.1(Y124F)-expressing (n=9) CHO cells 
(*P<0.05; 2-tailed t test). (c) (Left) Representative currents from Kv2.1(S800D)- and 
Kv2.1(Y124F, S800D)-expressing CHO cells. Calibration: 5nA, 25ms.   (Right) Mean ± SEM 
current densities from Kv2.1(S800D)-expressing (n=11) and Kv2.1(Y124F,S800D)-expressing 
(n=13) CHO cells (*P<0.05; 2-tailed t test).  (d) Y124F mutation disrupts Kv2.1-mediated 
apoptosis.  (Experiments performed by Elias Aizenman, Ph.D.).  CHO cells were cotransfected 
with eGFP plus empty vector and either Kv2.1 or Kv2.1(Y124F) and 24h later exposed to 30µM 
DTDP (15min).  Viability was assayed 24h post-treatment by counting GFP positive cells.  
Values represent the mean ± S.E.M. (n=3) and are representative of 3 separate, independent 
experiements (*P<0.05; ANOVA/Bonferroni).  
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3.4.3  Overexpression of Cyt-PTPε  blocks apoptotic K+ current surge.  Cyt-
PTPε dephosphorylates Y124, which can counteract enhanced Kv2.1 activity induced by src 
phosphorylation (Tiran et al., 2003; Tiran et al., 2006). Accordingly, we evaluated whether Cyt-
PTPε overexpression would be sufficient to disrupt Y124 phosphorylation and inhibit the 
apoptotic K+ current surge.  We performed whole-cell recordings in CHO cells co-expressing 
Kv2.1 and Cyt-PTPε following vehicle and DTDP treatment.  We observed that Cyt-
PTPε expression strongly inhibited the DTDP-induced K+ current surge (Fig. 9A), while co-
expression of a catalytically inactive mutant isoform (Cyt-PTPε-D245A) (Flint et al., 1997; 
Peretz et al., 2000) did not (Fig. 9B). Cyt-PTPε expression also strongly inhibited elevated K+ 
currents in Kv2.1(S800D)-expressing CHO cells (Fig. 10A,B).  Importantly, manipulation of 
Y124 phosphorylation, first via src inhibition (Fig. 7A, B) and now Cyt-PTPε overexpression, 
blocks the apoptotic K+ current surge.  These results show not only that Y124 is required, but it 
must be phosphorylated for the apoptotic Kv2.1-mediated current surge. 
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Figure 9.  Cyt-PTPε activity blocks apoptotic K+ current enhancement. (a) Cyt-PTPε and Kv2.1 
co-expression blocks apoptotic K+ current densities in CHO cells. (Left)  Representative steady 
state current/voltage relationship of Kv2.1- and Cyt-PTPε-expressing CHO cells recorded 
following vehicle (black) and DTDP treatment (white) conditions (30µM for 5min). Currents 
were obtained 3 h post oxidative injury.  (Right) Mean ± SEM current densities from Kv2.1- and 
Cyt-PTPε-expressing CHO cells recorded under control (n=16, black) and DTDP treatment 
(n=16, white) conditions. (b) Enzymatic activity of Cyt-PTPε is required for inhibition of 
apoptotic K+ current enhancement. (Left) Representative steady state current/voltage relationship 
of Kv2.1- and Cyt-PTPε(D245A)-expressing CHO cells recorded under control (black) and 
DTDP treatment (white) conditions. (Right)  Mean ± SEM current densities from Kv2.1- and 
Cyt-PTPε(D245A)-expressing CHO cells recorded under control (n=16, black) and DTDP 
treatment (n=16, white) conditions (*P<0.01; 2-tailed t-test). Current density was calculated as 
the steady state K+ current evoked by a single voltage step to +10mV from a holding potential of 
-80mV normalized to cell capacitance.   
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3.4.4  Intracellular Zn2+ regulates the apoptotic K+ current surge.  As 
mentioned earlier, overexpression of Cyt-PTPε inhibited elevated K+ currents in Kv2.1(S800D)-
expressing CHO cells (Fig. 10A,B), indicating that the current surge requires phosphorylation of 
both Y124 and S800.  However, following DTDP exposure we observed that Kv2.1(S800D)-
mediated K+ currents were elevated even in phosphatase-overexpressing cells (Fig. 10A,B).  This 
suggests that Y124 remains phosphorylated during oxidative injury in Kv2.1(S800D)-expressing 
cells.  Since DTDP exposure induces a dramatic rise in free intracellular Zn2+ (McLaughlin et al., 
2001; Bossy-Wetzel et al., 2004; Redman et al., 2007), we evaluated whether this metal was 
responsible for the apoptotic K+ current surge in DTDP treated Kv2.1(S800D)-expressing cells.  
We thus exposed CHO cells expressing Kv2.1(S800D) and Cyt-PTPε to DTDP in the presence 
of the Zn2+ chelator tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN; 10µM).  Under these 
conditions, Kv2.1(S800D)-mediated current densities were no longer enhanced (Fig. 10A, B), 
suggesting that Y124 phosphorylation is facilitated by Zn2+.  Treating Kv2.1(S800D) and Cyt-
PTPε-expressing cells with TPEN alone resulted in no significant changes in current density 
compared to control conditions (data not shown).  To confirm that the TPEN-elicited block of K+ 
current enhancement was specific to Zn2+ chelation, we treated Kv2.1(S800D) and Cyt-PTPε-
expressing cells with DTDP and equimolar concentrations of TPEN and ZnCl2 (10µM).  By 
preloading TPEN with Zn2+, we eliminated TPEN’s ability to chelate any DTDP-liberated Zn2+ 
because its metal binding sites are already occupied.  These cells showed a pronounced K+ 
current enhancement (Fig. 10A, B), again strongly suggesting a Zn2+-dependent modulation of 
Y124.  Since TPEN can also chelate iron, we treated Kv2.1(S800D)- and Cyt-PTPε-expressing 
cells with DTDP and equimolar concentrations of TPEN and FeCl2 (10µM).  In this experiment, 
any free Zn2+ would displace Fe2+ from TPEN, reducing the cytoplasmic free [Zn2+] while 
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increasing the free [Fe2+], as TPEN has a higher affinity for Zn2+ than for Fe2+ (Zn2+, KD=2.6x10-
16 Fe2+, KD=2.4x10-15).  As anticipated, these cells displayed no K+ current surge (Fig. 10A, B), 
confirming that Zn2+ is the metal species most likely responsible for ensuring Y124 
phosphorylation.  Because Cyt-PTPε overexpression did not prevent the K+ current surge in 
Kv2.1(S800D)-expressing cells when intracellular Zn2+ was available, Zn2+ inhibition of Cyt-
PTPε may potentially be the molecular mechanism leading to elevated K+ currents. 
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Figure 10.  K+ current surge is regulated by intracellular Zn2+.  (a) Representative whole-cell K+ 
currents from wild-type (wt) Kv2.1-, Kv2.1(S800D)- and Cyt-PTPε-expressing CHO cells 
recorded under control and DTDP treatment conditions (30µM for 5min).  Other cell groups 
were treated with tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN) alone (10µM) or in 
equimolar solutions (10µM) with FeCl2 or ZnCl2 in both the DTDP-treatment and post-treatment 
medium.  Currents were obtained 24h post-transfection, 3h post oxidative injury, and evoked by 
sequential 10mV voltage steps to +80mV from a holding potential of -80mV.  Calibration: 5nA, 
25ms. (b) Mean ± SEM current densities from wt Kv2.1- (n=14), Kv2.1(S800D)- (n=11), or 
Kv2.1(S800D) and Cyt-PTPε-expressing CHO cells treated with vehicle (n=15), DTDP (n=18), 
DTDP + TPEN (n=16), DTDP + equimolar TPEN and FeCl2 (n=20), or DTDP + equimolar 
TPEN and ZnCl2 (n=19) (significantly different from vehicle-treated WT Kv2.1-expressing cells, 
**P<0.01; *P<0.05; ANOVA/Dunnett).  
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3.4.5  Zn2+ inhibits catalytic activity of Cyt-PTPε .  To test whether Cyt-PTPε 
enzymatic activity is directly inhibited by Zn2+, we performed an in vitro phosphatase assay 
(Promega, Madison, WI) using immunopurified Cyt-PTPε  expressed in CHO cells.  As shown 
in Fig. 11, we observed a 50% inhibition in activity of Cyt-PTPε isolated from cells previously 
treated with 100µM extracellular Zn2+ and 1µM of the Zn2+-selective ionophore pyrithione.  This 
stimulus was used, rather than oxidative injury, as we found it difficult to recover sufficient 
amounts of active protein from DTDP-treated cells. The effect was reversed in Cyt-PTPε isolated 
from cells co-treated with 100µM Zn2+, 1µM pyrithione and 10µM TPEN (Fig. 11).  Moreover, a 
consistent increase in phosphatase activity was observed in Cyt-PTPε isolated from cells treated 
with TPEN alone (Fig. 11).  These data thus indicate that basal, endogenous levels of Zn2+ 
inhibit Cyt-PTPε  enzymatic activity, which may explain the large current densities observed in 
Kv2.1(S800D)-expressing cells.  Importantly, these results also suggest that disruption of Cyt-
PTPε activity operates in parallel with src and p38 (McLaughlin et al., 2001) activation, 
pinpointing the liberation of intracellular Zn2+ as the critical upstream signaling event required 
for Y124 and S800 phosphorylation during apoptosis (Fig. 13). 
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Figure 11.  Cyt-PTPε catalytic activity is inhibited by Zn2+.  Cyt-PTPε   was purified by 
immunoprecipitation from whole CHO cell lysates treated with either vehicle, Zn2+ (100µM) + 
pyrithione (1µM), Zn2+ + pyrithione+ TPEN (10µM), or TPEN, and added to a phosphatase 
assay containing 2 synthetic phosphotyrosine peptide substrates. Activity was normalized to Cyt-
PTPε recovered following immunoprecipitation and elution and is expressed as pmoles 
phosphate generated per µg protein (mean±S.E.M., n=6, significantly different from control, 
*P<0.05, **P<0.01, ANOVA/Dunnett). 
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3.4.6  Overexpression of Cyt-PTPε    attenuates neuronal cell death.  To 
confirm that Cyt-PTPε can modify endogenous Kv2.1-encoded channels, we performed 
recordings in vehicle- and DTDP-treated cortical neurons transfected with either empty vector or 
Cyt-PTPε.  While vector transfected neurons exhibited a robust, characteristic K+ current surge 
following DTDP treatment (Fig. 12A), Cyt-PTPε transfected neurons exhibited no K+ current 
increase (Fig. 12B).  Since overexpression of the phosphatase blocks the K+ current surge we 
evaluated whether it also affects the viability of cortical neurons exposed to activated microglia 
(Boeckman and Aizenman, 1996; Pal et al., 2003; Aras et al., 2008).  Activated microglia can 
mediate cell death in cortical neurons via a Zn2+ and K+ channel-dependent process in vitro 
(Knoch et al., 2008).  Cyt-PTPε -expressing neurons displayed an approximate 2-fold increase in 
viability compared to vector-expressing neurons exposed to activated microglia (Fig. 12C), 
almost identical to the rescue we observed in previous studies using Kv2.1 dominant negative 
isoforms (Pal et al., 2003; Knoch et al., 2008).  Taken together, these data suggest that Cyt-PTPε 
overexpression confers neuroprotection by its actions on Y124 and inhibition of the K+ current 
surge following an apoptotic insult. 
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Figure 12.  Overexpression of Cyt-PTPε   blocks Kv2.1-mediated neuronal cell death.  (a) K+ 
currents are enhanced in vector-expressing cortical neurons following oxidative injury. (Left) 
Representative whole-cell K+ currents from cortical neurons co-transfected with empty pRBG4-
vector eGFP recorded following vehicle and DTDP treatment conditions (30µM for 10min).  
Calibration: 5nA, 25ms.  (Right) Mean ± SEM current densities from empty pRBG4-vector- and 
eGFP-expressing cortical neurons recorded under control (n=11) and DTDP (n=10) treatment 
conditions (*P<0.01; 2-tailed t-test). Current density was calculated as the steady state K+ current 
evoked by a single voltage step to +10mV from a holding potential of -80mV normalized to cell 
capacitance.  (b) Overexpression of Cyt-PTPε blocks apoptotic K+ current densities in cortical 
neurons.  (Left) Representative whole-cell K+ currents from Cyt-PTPε- and eGFP-expressing 
cortical neurons recorded under control and DTDP treatment conditions.  Calibration: 5nA, 
25ms.  (Right) Mean ± SEM current densities from Cyt-PTPε- and eGFP-expressing cortical 
neurons recorded under control (n=10) and DTDP (n=10) treatment conditions.  (c) Cyt-PTPε 
overexpression blocks neuronal cell death following exposure to activated microglia.  
(Experiments performed by Karen Hartnett).  Viability was assayed 24 h post-treatment by 
luciferase activity and expressed as luciferase units. Values represent the mean ± SEM viability 
from each condition performed in triplicate and are representative of six separate, independent 
experiments. (***P<0.001,**P<0.01, ANOVA/Tukey). 
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Figure 13. Schematic of Kv2.1 illustrating the proposed effect of intracellular Zn2+ on the 
checkpoint-modifying enzymes src, Cyt-PTPε and p38.   The apoptotic K+ current surge 
observed in neuronal apoptosis is mediated by surface delivery of Kv2.1-encoded ion channels 
when intracellular residues Y124 and S800 are phosphorylated.  The dual phosphorylation state 
is achieved following intracellular Zn2+ liberation, which increases kinase activity while 
inhibiting phosphatase activity.  
 
 85 
 
3.5  Discussion 
 
The results presented here demonstrate that two different phosphorylation targets on 
Kv2.1, namely Y124 and S800, work in concert to regulate the apoptotic surge of K+ currents.  
Until now, direct p38 phosphorylation of Kv2.1 residue S800 was thought to be sufficient to 
account for the apoptotic K+ current surge mediating death of cortical neurons (Redman et al., 
2007).  Unlike S800, the majority of phosphorylation and dephosphorylation sites described for 
Kv2.1 modify channel gating properties (Park et al., 2006).  However, oxidative apoptotic injury 
does not alter the voltage-dependent gating of membrane-resident Kv2.1 channels (Yu et al., 
1997), as has been demonstrated in several non-injurious cellular environments (Misonou et al., 
2004; Misonou et al., 2005a).  In these latter instances, the Ca2+ activated phosphatase 
calcineurin mediates the dephosphorylation of numerous intracellular sites that cooperate in the 
graded regulation of channel activation and inactivation (Park et al., 2006).  Importantly, Y124 
and S800 are not calcineurin targets, and thus these sites do not participate in Kv2.1 gating 
during non-apoptotic conditions.  The present findings indicate that phosphorylation of 
previously characterized S800 (Redman et al., 2007) is not sufficient, and Y124 phosphorylation 
is required, for Kv2.1-mediated current enhancement during apoptosis.  Therefore, Y124 and 
S800 act as molecular checkpoints mediating the apoptotic K+ current surge and can strongly 
influence neuronal viability.  Remarkably, the cation ultimately controlling Kv2.1 channel 
phosphorylation at these sites and subsequent cell death is Zn2+, not Ca2+. 
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Earlier studies by Elson and colleagues (Tiran et al., 2003) identified Y124 as a novel 
substrate for direct phosphorylation and dephosphorylation reactions by src and Cyt-PTPε, 
respectively.  However, the role of Y124 on apoptosis had not been evaluated.  Src 
phosphorylation of Kv2.1 does not affect channel activation kinetics under normal conditions 
(Tiran et al., 2003), and single Kv2.1 channel analysis suggests that the K+ current enhancement 
observed in PTPε null mice are not due to differences in channel open probability (Peretz et al., 
2000; Tiran et al., 2006).  These findings, combined with the present data, indicate that the Y124 
phosphorylation dependent K+ current surge occurs by increasing the number of active 
membrane-resident channels during apoptosis (Pal et al., 2006).  Y124 phosphorylation is 
therefore critical to support the obligatory K+ current enhancement in dying cortical neurons, and 
can be achieved via a combination of src activation and/or Cyt-PTPε inhibition.  Nonetheless 
Y124 phosphorylation is required and must work in concert with p38 phosphorylation of S800, 
as a serine to alanine point mutation is sufficient to abolish the current surge (Redman et al., 
2007). 
 
 Although src is activated by endogenous Zn2+ liberation (Wu et al., 2002), Zn2+-activated 
src can not account for enhanced K+ currents observed under all conditions, as CHO cells 
expressing Kv2.1(S800D) mutant channels exhibit elevated currents without DTDP treatment 
(Fig. 8C, Fig. 10).  This apparent discrepancy could be explained by basal levels of src activity 
leading to Y124 phosphorylation.  Indeed, this would account for the decreased current densities 
observed in Kv2.1(S800D)-expressing cells transfected with Cyt-PTPε  (Fig. 10).  Alternatively, 
Kv2.1 could be more efficiently phosphorylated by src at Y124 with the S800 checkpoint already 
fulfilled by pseudo-phosphorylation.  However, as pharmacological inhibition of src was 
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sufficient to block injury-dependent K+ current surge in cortical neurons (Fig. 7), Zn2+-activated 
src is likely to be an important component in apoptotic endogenous channel trafficking.  Also, 
recent evidence suggests src tyrosine kinases enhance K+ currents mediated by hERG (Zhang et 
al., 2008) and Kv4.3 (Gomes et al., 2008) channels, but direct channel phosphorylation and the 
nature of K+ current augmentation has yet to be determined.  Although src activity is known to 
play a neurodegenerative function in various paradigms defined by altered Zn2+ homestasis (Paul 
et al., 2001; Volonte et al., 2001; Khanna et al., 2002; Lennmyr et al., 2004), a novel role for src 
signaling in a neurodegenerative process has been revealed by the work presented here: 
regulation of K+ channel trafficking. 
   
The present study has also established that the balance between Y124 phosphorylation 
and dephosphorylation is strongly modulated by Zn2+.  Our data show the Cyt-PTPε, which 
targets Y124 on Kv2.1 (Tiran et al., 2003), is inhibited by Zn2+.  Protein phosphatases can be 
inhibited by a number of injury induced cellular processes, including proteolytic cleavage (Gil-
Henn et al., 2001), dimerization (Toledano-Katchalski et al., 2003), and oxidation (Meng et al., 
2002).  There are also reports indicating that phosphatases are inhibited by Zn2+ in both cell free 
preparations (Brautigan et al., 1981; Haase and Maret, 2003, 2005b, a) and following cellular 
exposure to exogenous Zn2+ (Haase and Maret, 2003, 2005b; Kim et al., 2006; Tal et al., 2006).  
Notably, a recent report demonstrated inhibition of the MAPK phosphatase PP2A by endogenous 
Zn2+ following oxidative injury (Ho et al., 2008).  However, the present findings represent, to our 
knowledge, a novel persistent inhibition of a specific protein tyrosine phosphatase (Cyt-PTPε) by 
Zn2+.  The finding that Zn2+ can directly act on the highly conserved active site of protein 
tyrosine phosphatases at nanomolar concentrations (Haase and Maret, 2003) is highly suggestive 
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not only that Zn2+ may inhibit Cyt-PTPε directly, but may also exert powerful inhibitory effects 
on all PTPs, including others that may target Y124.  We recognize, however, that Zn2+ may also 
be inhibiting Cyt-PTPε by an unknown posttranslational modification or alteration in protein-
protein interactions.  For instance, Cyt-PTPε forms inactive monomeric and dimeric species 
under basal conditions that are stabilized during times of increased oxidative stress (Toledano-
Katchalski et al., 2003), but the role of Zn2+ in this process has yet to be examined.   
  
Although not widely reported in the current literature, convergence of multiple enzymatic 
signaling pathways mediating different phosphorylation events at membrane resident ion 
channels has been demonstrated, albeit in non-injurious circumstances.  (Moult et al., 2008) 
showed that p38 and an unspecified protein tyrosine phosphatase co-modify mGLuR2 subunits 
of AMPARs to mediate receptor internalization and long-term depression in the CA1 region of 
the rat hippocampus.  The present findings, combined with previous work, suggest a concurrent 
disruption in tyrosine phosphatase activity and enhancement of src and p38 (McLaughlin et al., 
2001) activity during apoptosis (Fig. 13).  Thus, the liberation of intracellular Zn2+ is a common 
upstream signal determining the phosphorylation both Y124 and S800.  With this work, we 
illustrate an essential regulatory event in the apoptotic program, as separate Zn2+-dependent 
signaling cascades converge at Kv2.1-encoded ion channels to mediate the apoptotic K+ current 
surge and neuronal death.   
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4.  Discussion 
 
Increases in intracellular free Zn2+ represent a ubiquitous signal for neuronal injury in 
neurodegenerative disorders.  Dysregulation of Zn2+ homeostasis by pathophysiological 
conditions, especially those in which reactive oxygen and nitrogen species have been implicated, 
is central to the progression of neuronal injury.  In addition, loss of cytoplasmic K+ appears to be 
an equally critical cell death catalyst downstream of the initial oxidant-induced Zn2+ release.  
Here, I have summarized the key molecular components that link the Zn2+ liberation to the loss 
of cytoplasmic K+ in apoptotic neurons.  Specifically, I have identified two requisite, Zn2+-
dependent phosphorylation events on Kv2.1, at Y124 and S800, that cooperatively mediate 
apoptotic K+ current enhancement.  Also, I have demonstrated that enzymatic activity of Cyt-
PTPε is inhibited by Zn2+.  This, in combination with previous observations that Zn2+ stimulates 
src and p38 activity, places this metal as a critical upstream signaling factor governing the dual 
phosphorylation checkpoint on Kv2.1 (Fig. 13).  By characterizing the signaling pathway linking 
these two events I have helped to elucidate essential mechanistic events that mediate neuronal 
cell death.  In this final chapter I will discuss some of the questions that arise from the present 
findings and how my results can be incorporated into the overall picture that is emerging for 
neuronal apoptosis. 
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4.1  The Zn2+-K+ continuum: a conserved cell death pathway? 
 
There is now evidence strongly suggesting that the apoptotic Zn2+-K+ continuum 
characterized in this study may be widespread in other cell death programs.  For instance, in 
addition to direct exposure to injurious oxidants (McLaughlin et al., 2001; Pal et al., 2004; Zhang 
et al., 2004), intraneuronal Zn2+ liberation is also a defining characteristic in acute 
neurodegenerative conditions such as epilepsy (Lee et al., 2000; Lavoie et al., 2007), and 
cerebral ischemia (Calderone et al., 2004).  Along these lines, our group has recently detected the 
release of intracellular Zn2+ followed by an apoptotic surge in K+ currents in cortical neurons 
exposed to oxygen-glucose deprivation (OGD) (Supplementary Fig. 3, 4). Also, Zn2+ 
dysregulation and K+ current enhancement have been implicated in the two most prevalent 
chronic neurodegenerative conditions: Alzheimer’s disease (AD) and Parkinson’s disease (PD).  
Importantly, this continuum of ionic dysregulation is not limited to neurodegenerative disease, as 
both intracellular Zn2+ release and K+ current enhancement are also characteristics of 
neurodevelopmental cell death (Hribar et al., 2004; Lee et al., 2006).  In the following section, I 
will discuss in greater detail how AD and PD, two disorders historically defined by distinct 
pathophysiology, share similar features of the apoptotic continuum of Zn2+ and K+ dysregulation.  
 
In the context of AD, significant Zn2+ elevations have been found in brain regions 
displaying severe pathological alterations in the diseased brain, such as the hippocampus 
(Cuajungco and Faget, 2003).  A defining feature of AD pathology is the accumulation of beta 
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amyloid (Aβ) comprised neuritic plaques, which are proteinacious deposits hypothesized to 
contribute to neurotoxicity.  Studies in vitro (Forloni et al., 1993) and in vivo (LaFerla et al., 
1995) have demonstrated that Aβ is neurotoxic, albeit by poorly defined mechanisms.  Zn2+ co-
localizes with beta amyloid (Aβ) plaques in transgenic mouse models of AD (Lee et al., 1999) 
and in human diseased brain tissue (Danscher et al., 1997; Suh et al., 2000), while chelation of 
Zn2+ facilitates plaque dissolution (Cherny et al., 1999; Regland et al., 2001; Ritchie et al., 2003; 
Friedlich et al., 2004) and solubilizes Aβ from deposits in post-mortem tissue from Alzheimer’s 
disease patients (Hensley et al., 1995).  Synaptically released Zn2+ significantly contributes to Aβ 
aggregation and toxicity in vivo, as transgenic mice lacking synaptic Zn2+ display an amelioration 
of Aβ pathology (Lee et al., 2002).  Zn2+ has been shown to promote Aβ-induced ROS 
generation (Huang et al., 1999) although it must be noted that other redox active metal ions, such 
as copper and iron, have also been shown to potentiate Aβ-induced ROS generation and toxicity 
(Cuajungco et al., 2000).  Because Zn2+ is not redox active, Zn2+ may be acting to coordinate Aβ 
aggregation, while downstream toxic ROS generation might be purely dependent on copper and 
iron.  In either case, Aβ-mediated ROS production may also be functioning as a positive 
feedback mechanism, leading to further Zn2+ liberation from intracellular metal-binding proteins.  
As p38 activation has also been shown in the AD brain (Hensley et al., 1999), and following 
introduction of exogenous Aβ (Giovannini et al., 2002), Zn2+-mediated ROS generation via Aβ 
could, in theory, lead to apoptotic p38 activation.  In fact, this putative signaling pathway closely 
resembles the Zn2+-mediated ROS generation by mitochondria and 12-LOX leading to p38 
activation following oxidant exposure (McLaughlin et al., 2001; Sensi and Jeng, 2004; Zhang et 
al., 2004).  Moreover, other putative Aβ signaling pathways may involve src family kinases, as 
mice deficient in fyn are resistant to Aβ-induced neurotoxicity (Lambert et al., 1998), further 
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suggesting that Zn2+-activated signaling pathways are a common component of apoptotic 
excecution.  
 
In addition to Zn2+ dysregulation, K+ channel dysfunction has also been implicated in the 
neurodegenerative processes of AD.  In rat cortical neurons exposed to Aβ, a selective 
enhancement in both transient and delayed rectifyer voltage-gated potassium current is detected 
prior to completion of the apoptotic program (Yu et al., 1998; Yu et al., 2006).  Very recently, 
another group provided evidence implicating Kv3.4 and accessory subunit MiRP2 as the 
molecular gateway responsible for the increased transient K+ current observed following Aβ 
exposure (Pannaccione et al., 2007).  The investigators observed a nuclear factor κB (NF-κB)-
dependent transcriptional co-upregulation of Kv3.4 and MiRP2, followed by increased channel 
membrane insertion prior to caspase activation and cell death (Pannaccione et al., 2007). The 
mechanism and Kv channel leading to elevated delayed rectifying currents was not identified, 
but the results from the present study suggest that Kv2.1 surface delivery via dual 
phosphorylation is most likely responsible, especially since oxidative stress, and Zn2+ 
dysregulation seem to be central to Aβ toxicity.  Importantly, blocking both the transient and 
delayed rectifying K+ current surge with selective antagonists was neuroprotective (Pannaccione 
et al., 2007; Yu et al., 2006), indicating that K+ efflux is also a critical event in Aβ-induced 
neuronal cell death. 
 
Relevant to Parkinson’s disease, several in vitro and in vivo models have demonstrated 
characteristics of a Zn2+-K+ continuum leading to neuronal death.  Parkinson’s disease pathology 
is characterized by dopaminergic cell death in the striatum and substantia nigra, and for the most 
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part, pre-clinical models of have made use of neurotoxins that selectively target dopaminergic 
neurons in these two brain regions.  For instance, the dopaminergic neurotoxin 6-
hydroxydopamine- (6-OHDA) has recently been shown to affect Zn2+ and K+ regulation.  6-
OHDA is transported into dopaminergic neurons by the dopamine transporter (DAT), where it 
has been suggested to mediate toxicity via oxidative signaling processes (Blum et al., 2001) and 
caspase-dependent apoptosis (Choi et al., 2004).  A considerable elevation in cellular Zn2+ levels 
has been observed in dopaminergic neurons in the 6-OHDA-induced rodent model of 
Parkinson’s disease (Tarohda et al., 2005), while 6-OHDA induced neurotoxicity is significantly 
exacerbated in mice lacking two out of three metallothionein isofoms expressed in the brain 
(MT-1 and MT-II null mice) (Asanuma et al., 2002).  Also, a significant increase in p38-
dependent, Kv2.1-mediated K+ currents was detected in dopaminergic neurons exposed to 6-
OHDA in vitro (Appendix; Redman et al., 2006), suggesting that the specific signal transduction 
pathway delineated in the present study is mediating apoptosis. However, it was also recently 
demonstrated that activation of ATP-sensitive potassium channels (K-ATP) participates in 
dopaminergic cell death in the substantia nigra following exposure to the dopaminerginc toxins 
rotenone and MPTP (Liss et al., 2005).  K-ATP channels are activated in response to the 
convergence of cellular energy depletion and increased ROS generation induced by 
mitochondrial disuptions. Along with K-ATP channel activation, metallothionein levels are 
significantly reduced in the substantia nigra of mice following a single neurotoxic injection of 
(MPTP) (Dhanasekaran et al., 2007).  Thus, a potential rise in intracellular Zn2+ resulting from 
removal of this metal-buffering protein may contribute to subsequent ROS generation and K+ 
channel activation.  Still, the molecular link between K-ATP activation and dopaminergic cell 
death following MPTP treatment has not been established.  It is quite possible that K-ATP 
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channels are facilitating an apoptotic K+ efflux similar to the requisite event mediated by Kv2.1 
in dopaminergic neurons exposed to 6-OHDA in vitro (Appendix; Redman et al., 2006).  On the 
other hand, because some K-ATP channels are localized at mitochondria, they represent 
additional putative targets of Zn2+-dependent mitochondrial disruption, in addition to Zn2+ 
activation of mitochondrial multi-conductance channels associated with cell death signaling 
molecules (Bonanni et al., 2006).  Therefore, Kv2.1-encoded channels are more likely mediating 
death via K+ efflux downstream of K-ATP-mediated neurotoxic signaling pathways.    
 
In summary, sequential disruption in Zn2+ and K+ homeostasis is associated with a range 
of neuronal cell death conditions, including chronic neurodegenerative disorders associated with 
oxidative stress, mitochondrial impairment and Aβ.  Although different disease states will 
undoubtedly involve multiple pathways participating in toxicity, if the Zn2+-regulated signaling 
molecules described in the present study are activated, they will likely participate through 
modulation of Kv2.1.  Also, it is possible that different K+ channels are able to provide multiple 
gates for K+ efflux, even in the same cell type, depending on the nature of the injury.  Thus, 
blocking the appropriate K+ channel population, like has been demonstrated here with Kv2.1, 
will be necessary to rescue cells from different neurotoxic insults. 
 
4.2  Mechanism of Cyt-PTPε  inhibition by Zn2+ 
   
The experiments presented in Chapter 2 indicate that Cyt-PTPε is inhibited by Zn2+, but 
the specific mechanism of Zn2+ inhibition remains unknown.  In this section, I will explore 
potential mechanisms regulating the Cyt-PTPε inhibition that was observed following treatment 
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of CHO cells with Zn2+ and immunopurification of the phosphatase.  Because Cyt-PTPε activity 
was measured as the function of the free phosphate generated after cellular Zn2+ exposure, cell 
lysis, and immunoprecipitation procedures, the inhibition of Cyt-PTPε by Zn2+ must be long 
lasting and highly resilient.  Recently, Ho et al. (2008) demonstrated a similar sustained 
inhibition of PP2A by endogenous Zn2+ following oxidative injury using an in vitro phosphatase 
assay, although the mechanism of inhibition was not explored.   As discussed earlier, protein 
phosphatases can be inhibited by oxidation-induced dimerization (Toledano-Katchalski et al., 
2003), oxidation of the catalytic cysteine residue (Meng et al., 2002), and posttranslational 
modifications (Toledano-Katchalski et al., 2003).  Because Zn2+ can enter mitochondria and 
induce the production of ROS (Manev et al., 1997), Zn2+ may inhibit Cyt-PTPε via an oxidative 
mechanism.  Indeed, a short (5 min) exposure to 100 µM Zn2+ during activation of Zn2+-
permeable ion channels was sufficient to induce mitochondrial ROS generation in neurons (Sensi 
et al., 1999).  Thus, the 30 min exposure to 100 µM Zn2+ and 1 µM pyrithione used in this study 
could potentially be inducing similar mitochondrial ROS generation capable of phosphatase 
inhibition.  However, either reversible oxidation of the active site or reversible oxidation induced 
dimerization are unlikely, due to the high concentration of the reducing agent dithiothreitol 
(DTT) present in the phosphatase assay buffer.  DTT was necessary to keep the immunopurified 
phosphatase active, and phosphatase activity was decreased with lower DTT concentrations (data 
not shown).  On the other hand, the catalytic cysteine sulfydryl group could have undergone 
irreversible oxidation to either a sulfinic or sulfonic acid, a modification that has been 
demonstrated with PTP 1B (Haase and Maret, 2005) and would be resistant to reduction and 
hence catalytic reactivation by DTT.  Thus, if Zn2+-induced ROS generation is responsible for 
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the prolonged inhibition in Cyt-PTPε, it is likely the result of irreversible oxidation of the 
catalytic domain. 
 
The finding that Zn2+ effectively inhibits T-cell PTP at nanomolar concentrations (Haase 
and Maret, 2003) by binding to the highly conserved catalytic domain suggests that a direct 
inhibitory effect of Zn2+ is also quite possible, especially at the concentrations used in this study 
(100 µM).  Interestingly, direct Zn2+ binding has been suggested to mediate sustained inhibition 
of purified dual specificity phosphatases exposed to oxidant-liberated Zn2+ (Ho et al., 2008). 
Because DTT has been shown to form a complex with free or readily accessible Zn2+ ions 
(Cornell and Crivaro, 1972), I was unable to examine direct inhibition by simply adding Zn2+ to 
the purified phosphatase reaction.  Moreover, Zn2+ inhibition of Cyt-PTPε would need to be 
resistant to DTT.  This situation may be possible, as Zn2+ chelators are ineffective at recovering 
catalytic activity once the purified protein is bound by Zn2+ in other systems (Zhuo and Dixon, 
1997).  Thus, DTT chelation of the inhibitory Zn2+ ion and reactivation of purified Cyt-PTPε is 
unlikely to be a confounding factor if Zn2+ is binding and inhibiting Cyt-PTPε during CHO cell 
exposure, further supporting the notion that the sustained inhibition of Cyt-PTPε observed in this 
study could also be the result of a direct Zn2+ interaction.  
 
Another possible scenario mediating Cyt-PTPε inhibition is a Zn2+-mediated post-
translational structural modification, such as phosphorylation, resulting in a protein subject to 
immunoprecipitation while retaining a catalytically inactive conformation.  Indeed, Zn2+-
mediated phosphorylation is responsible for the prolonged alteration in catalytic activity that has 
been demonstrated previously with PTP 1B (Haase and Maret, 2005).  Interestingly, the 
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alteration in PTP 1B signaling is regulated by several kinases, including protein kinase C (PKC) 
(Haase and Maret, 2005), an enzyme known to be activated by Zn2+ (Noh et al., 1999).   Thus, a 
Zn2+-dependent PKC phosphorylation event could, in theory, be modifying Cyt-PTPε leading to 
sustained inhibition, particularly if Zn2+-dependent phosphatase inhibition is widespread and the 
phosphatase that normally reverses the PKC phosphate addition is inactive. Regardless of the 
molecular mechanism, the data suggest a sustained Cyt-PTPε inhibition by Zn2+, which in the 
context of oxidant-induced neuronal cell death would act as an effective cellular strategy for 
supporting Y124 phosphorylation, Kv2.1 surface delivery, and apoptosis. 
   
4.3 Signal transduction pathways from Zn2+ to Kv2.1: other considerations. 
 
The results presented in this dissertation, in addition to previous work, suggest the 
following model connecting oxidative Zn2+ liberation to the loss of cytoplasmic K+ in apoptotic 
neurons:  Zn2+ stimulates src and p38 activity while inhibiting Cyt-PTPε, thus facilitating the 
dual phosphorylation of Kv2.1 at Y124 and S800, followed by channel surface delivery and 
apoptotic K+ efflux (Fig. 13).  However, further studies are required to determine the specific 
molecular interactions between p38, src, Cyt-PTPε and Kv2.1, as well as other apoptotic 
signaling molecules implicated in Zn2+ and K+ dysregulation and neuronal cell death.  Certainly, 
the literature suggests additional possibilities of p38, src and PTPε interactions that may be 
regulating the neuronal apoptotic program. 
 
Different Kv2.1-targeting PTP isoforms may regulate apoptotic channel surface delivery 
by modulating other proteins in the proposed pathway, in addition to Y124 phosphorylation.  
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Along with Cyt-PTPε, Y124 is also a substrate of RPTPε and RPTPα (Tiran et al., 2006).  Both 
RPTPε and RPTPα, but not Cyt-PTPε, have been shown to activate src in vitro and in vivo via 
dephosphorylation of the inhibitory tyrosine 527 (Tiran et al., 2006).  As such, perhaps RPTPα 
or RPTPε mediated basal src activation is the reason for elevated currents observed in 
Kv2.1(S800D)-expressing CHO cells (Fig.10).  Nevertheless, the fact that RPTPε and RPTPα 
can both activate src and block the Y124 checkpoint, while Cyt-PTPε only targets Y124, 
suggests that different PTP isoforms perform distinct and overlapping roles in Kv2.1 modulation 
during neuronal apoptosis.   
 
Interestingly, Cyt-PTPε  expression strongly inhibits activity of downstream reporters of 
p38 MAPK activation during non-injurious conditions (i.e. transcription factor CHOP; Toledano-
Katchalski et al., 2003b), although direct p38 inhibition has not been tested.  As Cyt-PTPε 
 directly inactivates ERK1/2 MAPK (Toledano-Katchalski et al., 2003a), it is not unreasonable to 
propose p38 as an additional potential target for Cyt-PTPε activity, thereby negatively regulating 
both Kv2.1 and p38 activity.  There is also evidence indicating that src can activate p38 by an 
unknown mechanism following cellular glutathione depletion (Cuadrado et al., 2003).  Thus, like 
Kv2.1, p38 activity may also be regulated by the balance between src-mediated phosphorylation 
and Cyt-PTPε-mediated dephosphorylation.   Furthermore, Cyt-PTPε may be responsible for 
inhibiting channel surface expression by dephosphorylating both Kv2.1 and p38, effectively 
blocking both N- and C-terminal checkpoints during non-injurious conditions through direct and 
indirect phosphatase signaling. 
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Along with evidence indicating src and p38 are both regulated by PTPε, functional 
interactions have also been demonstrated between src and p38 kinase pathways.  As mentioned 
above, src is known to activate p38 (Cuadrado et al., 2003), while reciprocal activation of src by 
p38 has also been demonstrated (Volonte et al., 2001).  Because both kinase pathways are 
activated by Zn2+ and converge at Kv2.1, the function of reciprocal activation in the proposed 
model would serve to amplify the current enhancement even more.  This interaction of Zn2+-
dependent pathways prior to convergence at Kv2.1 might serve to activate both src and p38 
proteins that are localized in a Zn2+-deficient subcellular domain.  Even so, if Zn2+ is present at 
the appropriate subcellular localization and concentration, it could rapidly modulate all of the 
signaling enzymes in the vicinity.  For instance, metallothionein proteins could be positioned in 
close proximity to p38, src and Cyt-PTPε, effectively releasing Zn2+ to readily influence nearby 
signaling molecules following an oxidative insult. Such a scenario has been reported with 
calcineurin regulation of Kv2.1, as channel clusters lie in close proximity to endoplasmic 
reticulum derived subsurface cisternae rich in ryanodine Ca2+ channels (Misonou et al., 2005).  
Also, as Zn2+-induced injury has shown to be blocked by antagonists of Zn2+ influx, such as 
Ca2+-permeable voltage- and glutamate-gated ion channels (Colvin et al., 2003), exogenous Zn2+ 
influx could function to modulate enzymes localized at the plasma membrane.  This is 
particularly applicable to the Zn2+-K+ neuronal cell death pathway, as Zn2+ may be inhibiting the 
other membrane localized PTPs that share functional redundancy to Cyt-PTPε and target Kv2.1, 
namely RPTPε and RPTPα (Tiran et al., 2006), in addition to activating src and p38.  Perhaps 
the most efficient system for achieving dual Kv2.1 phosphorylation via localized Zn2+ signaling 
would be the consolidation of relevant signaling enzymes with the channel into a Zn2+-accessible 
protein complex.  Such a “macro-molecular” signaling complex has been demonstrated before 
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containing the K+ channel Kv7.1, the auxillary subunit MinK, protein kinase A and protein 
phosphatase 1, and is required for channel modulation via phosphorylation and 
dephosphorylation (Marx et al., 2002).    
 
4.4  How does phosphorylation lead to channel insertion? 
 
Another issue that requires further experimentation is the mechanism K+ current 
enhancement following dual Kv2.1 phosphorylation.  Previous observations from our laboratory 
indicate that cleavage of the SNARE proteins SNAP-25 and syntaxin is sufficient to block the 
apoptotic K+ current enhancement (Pal et al., 2006).  SNAP-25 forms a direct physical 
association with the cytoplasmic N-terminal (MacDonald et al., 2002), while syntaxin and 
syntaxin/SNAP25 t-SNARE complex directly interact with a membrane proximal region of the 
intracellular C-terminal of Kv2.1, defined as the C1a region (Leung et al., 2003; Tsuk et al., 
2005).  Recent findings indicate that Kv2.1 also interacts with the vesicular SNARE (v-SNARE) 
protein VAMP2 in brain membranes and Xenopus oocytes (Lvov et al., 2008).  However, the 
interaction of individual SNARE proteins with Kv2.1 is eliminated upon construction of the full 
SNARE complex (syntaxin/SNAP-25/VAMP2) (Tsuk et al., 2008). In addition, overexpression 
of syntaxin 1A and Kv2.1 can inhibit channel surfacing leading to a decrease in Kv2.1-mediated 
current density (Leung et al., 2003).  Very recently, it has been demonstrated that the Kv2.1 C-
terminal association with syntaxin 1A directly facilitates an increase in dense-core vesicle 
exocytosis following elevation in cytoplasmic Ca2+ (Singer-Lahat et al., 2007).  These various 
observations suggest that changes in phosphorylation state of Y124 and S800 lead to changes in 
association of the exocytotic SNARE protein machinery with the channel.  A similar 
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“biochemical switch” situation has been observed in other systems, where phosphorylation of N-
type Ca2+ channels by PKC or CAMKII leads to inhibition of binding with both syntaxin and 
SNAP-25 (Yokoyama et al., 1997), although the physiological significance of this switch is not 
known.   
 
Because the effect of sytnaxin 1A binding on phosphorylation-mediated Kv2.1 
trafficking has not been examined extensively, it represents an important subject for future 
studies.  For instance, whether the phosphorylation state of Y124 and S800 is responsible for 
Kv2.1 association with syntaxin 1A could easily be assayed in a recombinant expression system 
using Kv2.1 mutant channels and syntaxin 1A overexpression, followed by immunoprecipitation.  
Also, whether the C1a syntaxin binding domain is necessary for p38 phosphorylation of S800 
could be determined in a recombinant expression system overexpressing channels lacking C1a 
followed by cell lysis and immunostaining with our phospho-S800 antibody. 
 
Changes in physical association with other proteins known to interact with Kv2.1 may 
also play a role in surface delivery following phosphorylation.  For instance, association between 
Kv2.1 and an undefined retention scaffolding protein associated with the actin cytoskeleton is 
hypothesized to regulate lateral diffusion of channels between their well characterized clustered 
subcellular distribution in neurons (O'Connell et al., 2006), and changes in intracellular termini 
phosphorylation state are thought to determine this association.  Whether unclustering 
accompanies phosphorylation-dependent apoptotic surface delivery in our paradigm is unknown. 
Along these lines, disruption in the actin cytoskeleton prevents the apoptotic K+ loss and 
subsequent loss in cell volume and DNA fragmentation in Jurkat-T cells following Fas-L or UV 
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exposure (Bortner et al., 2008).  As such, regulation of channel trafficking and gating may be 
dependent on maintenance of cytoskeletal architecture as well.  Also, K+ channel β-subunits can 
control trafficking and surface expression of K+ channel α subunits, in addition to modulating 
channel activity (Shi et al., 1996).  Although only Kv1 and Kv4 channel subfamilies have 
historically been associated with β subunits, there is some evidence that Kv2.1 forms 
endogenous heteromeric associations with Kv9.3 (Coma et al., 2002).  As mentioned above, 
intracellular N- and C-termini of Kv2.1 have been shown to interact physically (Kobrinsky et al., 
2006; Mohapatra et al., 2008), and this interaction is required for efficient channel trafficking to 
the plasma membrane (Mohapatra et al., 2008).  It has been demonstrated that a 17 amino acid 
sequence located within the N-terminal T1 domain (residues 55-71), the region corresponding to 
the β subunit binding site in Kv1 and Kv4 channels, is required for both N- and C-terminal 
interaction and Kv2.1 channel surface expression (Mohapatra et al., 2008). It is thus also 
probable that conformational changes in intracellular N- and C- termini, mediated by Y124 and 
S800 phosphorylation, determine Kv2.1 trafficking during apoptosis, similar to the changes in 
Kv2.1 channel activity mediated by altered intracellular associations between termini (Kobrinsky 
et al., 2006).   
 
The molecular consequence of dual phosphorylation of Kv2.1 may be similar to the 
regulation of src, where one phosphorylation event initiates a steric shift that allows a second 
kinase access to its phosphorylation site.  It should be possible to probe whether p38 
phosphorylation of S800 is dependent on src phosphorylation of Y124 by using our phospho-
S800 antibody in combination with wild-type Kv2.1 and Kv2.1(Y124F) mutant channels.  Also, 
probing whether src phosphorylation of Kv2.1 is dependent on the p38 phosphorylation event 
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could be achieved, in theory, by using wild-type Kv2.1, Kv2.1(S800A) and Kv2.1(S800D) 
mutant channels in combination with the Cyt-PTPε(D245A) substrate trapping mutant.  Elson 
and colleagues have shown that Cyt-PTPε(D245A) is less likely to bind a dephosphorylated 
Y124 (Tiran et al., 2003), and thus the mutant phosphatase could be used as an assay for Y124 
phosphorylation by looking for changes in association between channel and phosphatase.  In 
other words, future studies could determine if the phosphorylation sites are inderdependent, and 
whether the order of phosphorylation events is a critical factor for channel surface delivery. 
 
4.5  Concluding remarks 
 
In this dissertation, I have characterized an important signaling pathway regulating 
neuronal cell death by identifying key molecular components that link oxidant-induced Zn2+ 
liberation to the loss of cytoplasmic K+ in apoptotic neurons.  Specifically, I have identified two 
essential phosphorylation sites on Kv2.1, at Y124 and S800, that cooperatively mediate the 
apoptotic K+ current surge and neuronal cell death.  Also, I have demonstrated that enzymatic 
activity of Cyt-PTPε is inhibited by Zn2+.  As Zn2+ has also been demonstrated to activate src and 
p38, this cation is an important signaling factor governing the dual phosphorylation of Kv2.1.  
The work presented here provides a more complete understanding of neuronal apoptotic 
processes by highlighting the importance of intracellular signaling cascades accompanying ionic 
dysregulation.  As these processes may be widespread, this work also provides possible novel 
therapeutic targets for a range of neurodegenerative disorders.  
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APPENDIX 
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Supplementary Figure 1. Generation of phospho-specific antibody. Antisera specific for the 
phosphorylated p38 MAPK consensus sequence of Kv2.1 (pKv2.1) was produced in rabbits 
immunized with a keyhole limpet hemocyanin-conjugated peptide with the sequence C-
KNHFESSPLPTS(p)PKFLR. Protein samples were generated from CHO cells expressing either 
WT Kv2.1 or the mutant Kv2.1(S800A). Cells were treated with 25 mM DTDP (5 min) 3 h 
before harvesting. (A) Immunoblots probed with a commercial Kv2.1 antibody (Alomone; 
1:3,000) or serum from immunized rabbits (pKv2.1). PI, preimmune serum (1:3,000); TB, test 
bleed (1:3,000); PB, production bleed (1:3,000). (B) Immunoblots probed with either Kv2.1 
(1:3,000) or pKv2.1 (1:12,000) antibodies under control conditions (C), or after an overnight 
incubation of the nitrocellulose membrane with alkaline phosphatase (AP; 100 units/ml) 
containing buffer (50 mM Tris-HCl, 1 mM MgCl2, 0.1 mM ZnCl2, 0.1 mM EDTA, 45% 
glycerol, pH 8.5) at 36°C. Note that the signal for the phospho-specific antibody is abolished by 
the phosphatase treatment. (C) Immunoblots probed with either Kv2.1 (1:3,000) or pKv2.1 
(1:12,000) antibodies on protein samples from CHO cells expressing either Kv2.1 or 
Kv2.1(S800A). Note the lack of phospho-specific signal for the mutant channel. 
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Supplementary Figure 2. Immunodetection of neuronal Kv2.1 protein. Equal amounts of 
protein were separated by 6% reducing SDS/PAGE and transferred to nitrocellulose membranes. 
The resulting blots were probed with affinity-purified rabbit polyclonal antibodies specific for 
either the C terminus of Kv2.1 (Alomone Labs) or pS800 of Kv2.1. Both antibodies reacted with 
the 80-kDa band as well a diffuse band with a molecular mass of »100 kDa. Preincubation of the 
two antibodies with their respective synthetic immunizing peptides eliminated both 
immunoreactive signals. 
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Supplementary Figure 3. Oxidative injury induces intracellular zinc release.  Experiments 
completed by Megan Knoch, Ph.D. Cortical neurons were loaded with the Zn2+-sensitive 
fluorescent reporter Fluozin-3 AM (5µM for 30min) and then perfused with DTDP (100µM for 
5min).  Images were acquired with a 485 nm excitation light (top). Following DTDP exposure, 
cells were treated with 20µM TPEN to chelate free intracellular Zn2+ and images were again 
acquired at 485 nm (bottom).    (b) Zn2+ release following an ischemic insult.  Data represents 
TPEN sensitive intraneuronal Zn2+ 4 hours after 30 minutes of oxygen-glucose deprivation 
(OGD; n=3) or 30 minutes non-OGD control exposure (glucose-containing salt solution; n=3).  
Following OGD, neurons were loaded with the Zn2+-sensitive fluorescent reporter Fluozin-3 AM 
(5µM for 30min).  Images were then acquired with 485 nm excitation light.  Baseline images 
were acquired and then cells were treated with 20µM TPEN to chelate free intracellular Zn2+.  
Relative Zn2+ fluorescence for all neurons was determined by subtracting the Fluozin-3 AM 
signal after TPEN application from the baseline Fluozin-3 AM signal (ΔFTPEN).  Data represent 
pooled (Mean±SEM) TPEN sensitive Zn2+ fluorescence measurements from 3 coverslips, each 
containing 5-15 cortical neurons.  
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Supplementary Figure 4.  OGD induces an apoptosis-associated K+ current enhancement.  
Experiments completed by Megan Knoch, Ph.D. Whole cell potassium currents were obtained 
from non-OGD exposed control cortical neurons (n=10), cortical neurons following 105 minutes 
of OGD (n=22), cortical neurons following 105 minutes of OGD in 25µM TPEN (n=12), and 
cortical neurons following 105 minutes of OGD in 20µM SB293063 (n=15). Recordings were 
performed 3 hours after each treatment condition, as at this time point the apoptotic K+ current 
enhancement is reliably detected.  Potassium currents were evoked by a single voltage step to 
+10mV from a holding potential of -80mV.  Current amplitudes were normalized to cell 
capacitance.  Mean ± SEM; *P<0.001, (ANOVA followed by Tukey-Kramer multiple 
comparisons test). 
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ABSTRACT 
6-hydroxydopamine (6-OHDA), a neurotoxic substrate of the dopamine transporter 
(DAT), is widely used in Parkinson’s disease models. However, the molecular mechanisms 
underlying 6-OHDA’s selectivity for dopamine neurons and the injurious sequelae that it triggers 
are not well understood.  We tested whether ectopic expression of DAT induces sensitivity to 6-
OHDA in non-dopaminergic cortical neurons and evaluated the contribution of Kv channel-
dependent apoptosis to the toxicity of this compound in cortical and midbrain dopamine 
neurons.  Cortical neurons expressing DAT accumulated dopamine and were highly vulnerable 
to 6-OHDA.  Pharmacological inhibition of DAT completely blocked this toxicity.  We also 
observed a p38-dependent Kv current surge in DAT-expressing cortical neurons exposed to 6-
OHDA, and p38 antagonists and Kv channel blockers were neuroprotective in this model.  Thus, 
DAT-mediated uptake of 6-OHDA recruited the oxidant-induced Kv channel dependent cell 
death pathway present in cortical neurons.  Finally, we report that 6-OHDA also increased Kv 
currents in cultured midbrain dopamine neurons and this toxicity was blocked with Kv channel 
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antagonists.  We conclude that native DAT expression accounts for the dopamine neuron specific 
toxicity of 6-OHDA.  Following uptake, 6-OHDA triggers the oxidant-associated Kv channel-
dependent cell death pathway that is conserved in non-dopaminergic cortical neurons and 
midbrain dopamine neurons. 
 
INTRODUCTION 
Parkinson’s disease is characterized by the loss of midbrain dopaminergic neurons.  For 
over 35 years, the catecholamine-derived neurotoxin 6-hydroxydopamine (6-OHDA) has been 
used to induce dopaminergic cell death in various models of this disorder (Przedborski and 
Ischiropoulos, 2005).  However, at sufficiently high concentrations all catecholamine derivatives, 
including dopamine and norepinephrine, induce non-selective cell death due to the generation of 
reactive oxygen species and reactive quinones following auto-oxidation (Heikkila and Cohen, 
1972; Rosenberg, 1988).  As such, the selectivity of 6-OHDA for dopaminergic neurons, under 
the right experimental circumstances, may be due to the distinct neurochemical properties of this 
cell type and/or the fact that the catecholaminergic toxin acts as a substrate for the dopamine 
transporter (DAT), unique to these cells (Blum et al., 2001).  Nonetheless, in spite the 
widespread use of 6-OHDA, the precise molecular mechanism by which this toxin destroys 
dopaminergic neurons has not been fully delineated, although many mechanisms have been 
proposed (Blum et al., 2001).  Here, we first examined whether DAT expression in non-
dopaminergic neurons would be sufficient to render these cells selectively sensitive to 6-OHDA 
toxicity.  In addition, the molecular mechanism of 6-OHDA-induced cell death in this artificial 
system was later confirmed to exist in dopaminergic neurons, revealing a potentially new 
neuroprotective strategy for Parkinson’s disease and related disorders.         
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EXPERIMENTAL PROCEDURES 
Green enhanced fluorescent protein, GFP, was from Clontech (Palo Alto, CA).  GFP-DAT 
cDNA was kindly provided by Dr. S. Amara (Pittsburgh, PA, USA).  Luciferase, pUHC13-3, 
was from Dr. H. Bujard (Heidelberg, Germany).  Tyrosine hydroxylase antibody was from 
Chemicon (Temecula, CA, USA).  Stromatoxin was purchased from Alomone (Jerusalem, 
Israel).  Freshly prepared 6-OHDA (Sigma Chemical Co., St. Louis, MO, USA) stocks (10 mM) 
were prepared in 0.15% ascorbate and kept at –80oC until ready to use.  Exposure vehicle 
consisted of minimum essential medium (without phenol red) with 25 mM HEPES and 0.01% 
bovine serum albumin.  Solutions of 100 µM 6-OHDA in the exposure vehicle were prepared 
immediately (<1 min) prior to use, as they auto-oxidized at neutral pH at a rate of approximately 
30% per minute at room temperature, as measured spectrophotometrically (490 nm).  No further 
auto-oxidation products were noted beyond 6-7 minutes.  Cortical cultures were prepared from 
E16 rat embryos as previously described (Hartnett et al., 1997).  Cultures were transfected at 18-
22 DIV with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA; Pal et al., 2003; ~5% 
transfection efficiency).  Cells were maintained for 24 to 48 hours at 37oC, 5% CO2 prior to 
recording and toxicity assays.  [3H]-Dopamine (DA) uptake assays were performed as described 
in Prasad and Amara (2001).  Uptake was performed for 5 minutes at room temperature in 
Ringer's solution containing 1 µM catechol-O-methyltransferase inhibitor Ro 41-0960 (Sigma), 
and 50 nM 3H-dopamine (60 Ci/mmol; PerkinElmer, Wellesley, MA, USA).  Ventral 
mesencephalic cultures were established from postnatal day 1 rat (Cardozo and Bean, 1995). 
Briefly, dissected tissue was dissociated with 20 U/ml papain (Worthington Biochemicals, 
Lakewood, NJ, USA) and triturated.  The cell suspension was layered onto Basal Medium Eagle 
solution containing 10 mg/ml trypsin inhibitor 10 mg/ml bovine serum albumin and spun for 8 
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min at 200 g.  The pellet was resuspended and cells plated at a density of 35,000 cells per 31 mm 
poly-L-lysine-coated glass coverslip.  Cultures were fed twice weekly with Basal Medium Eagle 
with N2 supplement (Gibco, Carlsbad, CA, USA), penicillin/streptomycin, 2% rat serum, 0.6 
mM glutamine, 10 mM glucose, and 10 mM HEPES; pH 7.3.  Electrophysiological and toxicity 
experiments were performed at >12 DIV.  At this in vitro age, functional expression of the DAT 
is well established (Valchar and Hanbauer, 1995) and, in our hands, the cells become highly 
vulnerable to 6-OHDA.  We compared the sensitivity of dopaminergic neurons to 6-OHDA 
toxicity (100 µM, 15 min exposure) at two developmental stages, 8 DIV (n=5) and 15 DIV 
(n=9).  We observed that viability of the younger cells was much grater than in the older cells 
following the toxin exposure (84.7 ± 15.4% at 8 DIV vs. 44.2 ± 5% at 15 DIV; p<0.01).  
 
Recordings were conducted using the whole-cell configuration of the patch-clamp 
technique as described previously (McLaughlin et al., 2001). The extracellular solution contained 
(in mM): 115 NaCl, 2.5 KCl, 2.0 MgCl2, 10 HEPES, 10 D-glucose, pH 7.2, 0.1 mM 
tetrodotoxin. The electrode solution contained (in mM): 120 K-gluconate, 11 EGTA, 10 KCl, 1 
MgCl2, 1 CaCl2,10 HEPES, 0.22 ATP; pH 7.2 and osmolarity adjusted to 280 mOsm with 
sucrose. Measurements were obtained under voltage clamp with an Axopatch 200 amplifier 
(Axon Instruments, Foster City, CA) and pClamp software (Axon Instruments) using 2 MΩ 
electrodes. Partial compensation (80%) for series resistance was always performed. Currents 
were filtered at 2 kHz and digitized at 10 kHz (Digidata; Axon Instruments). Potassium currents 
were evoked with a series of incremental positive voltage steps from a negative holding 
potential.  Steady-state current amplitudes were leak-subtracted (P/N protocol), and normalized 
to cell capacitance. Capacitive transients were subtracted manually with the amplifier built-in 
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circuits.  Transfected cortical neurons were identified by GFP fluorescence.  DA neurons were 
identified by fluorescence by 5,7-dihydroxytryptamine (Cardozo and Bean, 1995). We found that 
5,7-dihydroxytryptamine incubation could diminish the neurotoxic consequences of 6-OHDA 
exposure.  As such, 6-OHDA treatments always preceded labeling.    
 
Toxicity assays in cortical neurons were conducted at 48 hours post-transfection in 
parallel with electrophysiological recordings, but in luciferase co-transfected cells (Boeckman 
and Aizenman, 1996; Pal et al., 2003), or, in untransfected cells by a lactate dehydrogenase 
release assay (Hartnett et al., 1997).  Cells were rinsed immediately prior to drug treatment.  
Cells were exposed to either vehicle or 6-OHDA for 15 min at 37oC, 5% CO2. Luciferase activity 
as an index of cell viability (Boeckman and Aizenman, 1996) was measured using the GeneLux 
Kit (Perkin Elmer, Boston, MA, USA) in a Victor2 Multilabel Counter (Perkin Elmer).  Since we 
found that the potassium channel blocker tetraethylammonium (TEA) interfered with luciferase 
expression, toxicity assays involving this drug were quantified by cell counting of GFP-positive 
neurons.  Counts were obtained from 30 fields of a 40X objective per condition, in triplicate.  
Toxicity in mesencephalic cultures (15 DIV) was determined by cell counts of tyrosine 
hydroxylase positive cells 24 hours after 6-OHDA treatments.  Counts were conducted by 
determining the total number of TH positive cells in the entire culture dish, with at least 2-3 
culture dishes per condition, using a 20X objective. 
 
RESULTS 
We first provide evidence of a functional separation between dopaminergic neuronal 
phenotype and DAT function in the toxicity of 6-OHDA.  Non-dopaminergic rat cortical neurons 
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in culture were transfected with a plasmid encoding a GFP-DAT fusion protein (Fig. 1A), and its 
functional expression confirmed by [3H]-dopamine uptake.  We observed a significant increase 
in [3H]-DA uptake in GFP-DAT expressing cells, when compared to neurons transfected with a 
GFP-only expression vector (Fig. 1B).   We then tested whether the catecholaminergic 
neurotoxin 6-OHDA would preferentially injure the GFP-DAT-expressing cortical neurons.  A 
15 min exposure to 100 µM 6-OHDA, which was relatively innocuous to untransfected cortical 
neurons (Fig. 1C), or cortical neurons expressing GFP-only vector (Fig. 1D), was sufficient to 
kill approximately 50% of the GFP-DAT expressing cortical neurons (Fig. 1D).  In contrast, the 
glutamatergic toxin N-methyl-D-aspartate (200 µM, 15 min) killed neurons equally well, 
regardless of the expression of GFP-DAT (Fig. 1D).  The toxicity of 6-OHDA in GFP-DAT-
expressing cortical neurons was dependent on the activity of the transporter as it was completely 
blocked by the DAT inhibitor GBR12909 (Fig. 1E).  This situation is highly reminiscent of the 
conditions necessary to induce 50% apoptotic cell death in dopaminergic neurons in vitro (Ding 
et al., 2004).  As such, the expression of DAT is necessary and sufficient to render non-
dopaminergic neurons selectively susceptible to 6-OHDA toxicity under conditions where the 
extracellular auto-oxidation of the toxin induces little or no non-specific injury. 
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Figure 1.  DAT renders non-dopaminergic neurons sensitive to 6-OHDA.  A, Micrograph 
showing the expression of GFP-DAT in transfected cortical neurons (bar, 80 µm).  B, Expression 
of GFP-DAT in cultured cortical neurons leads to functional expression of the transporter as 
measured by [3H]dopamine (DA) uptake, which is not observed in GFP vector alone-expressing 
cultures.  Values represent the m ± s.e.m.uptake (fmol/min) in three independent experiments (*p 
< 0.005; t-test).  Inset: GFP-DAT expressing neuron. C, Concentration-toxicity relationship for 
naïve, untransfected cortical neurons exposed to increasing levels of 6-OHDA for 15 min.  
Toxicity was measured by a lactate dehydrogenase (LDH) release assay (n=4).  D, 6-OHDA is 
toxic to GFP-DAT expressing cortical neurons.  GFP-DAT and GFP expressing cortical neurons 
were exposed to 6-OHDA (100 µM, 15 min) or to NMDA (200 µM, 15 min).  Viability was 
assayed by a luciferase cell survival assay 24 hr. later and expressed as a percent of vehicle-
treated control (n=6-10).  Note that 6OHDA induced 50% cell death in GFP-DAT expressing 
neurons but was not lethal to GFP-expressing cells.  In contrast, NMDA was equally toxic to 
both types of neurons (*p<0.001; t-test).  E, 6-OHDA toxicity in GFP-DAT expressing cortical 
neurons is blocked by a DAT uptake inhibitor and by a p38-MAPK antagonist.  GFP-DAT 
expressing cortical neurons were exposed 100 µM 6OHDA (15 min) in the absence or presence 
of either 10 µM GBR12909 (a DA uptake inhibitor) or 20 µM SB29063 (a p38 inhibitor).  
Viability was assayed by a luciferase cell survival assay.  Note that both these drugs prevented 
6OHDA toxicity (n= 4-13; *p<0.01; ANOVA/Dunnet).   
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Dopaminergic neurons treated with 6-OHDA undergo caspase-dependent cell death 
following the phosphorylation of the mitogen-activated protein kinase (MAPK) p38 (Choi et al., 
2004).  As such, we tested whether the p38 antagonist SB239063 could block 6-OHDA-induced 
toxicity in GFP-DAT expressing cortical neurons.  We observed that SB239063 was indeed very 
effective in preventing cell death induced by the neurotoxin (Fig. 1E).  We have previously 
reported that oxidative stress in cortical neurons leads to a p38-dependent enhancement of 
voltage-dependent K+ currents (McLaughlin et al., 2001). This K+ current surge, mediated by the 
membrane insertion of Kv2.1-encoded K+ channels, is required for apoptosis to occur, and 
precedes caspase activation (McLaughlin et al., 2001; Pal et al., 2003; Pal et al., 2006).  
Therefore, we investigated if 6-OHDA activated a similar, p38-dependent pathway in GFP-DAT 
expressing cortical neurons.  A pronounced, toxin-induced K+ current surge was observed in 
these cells, which was completely suppressed by SB239063 (Fig. 2A).  More critically, the K+ 
channel blocker tetraethylammonium (TEA; Fig. 2B) was neuroprotective against 6-OHDA in 
GFP-DAT expressing cortical neurons, similar to what we have observed for other oxidant 
stressors (McLaughlin et al., 2001).  These data show that DAT-dependent 6-OHDA toxicity can 
activate a cell death pathway that is very similar to that triggered by other oxidants in cortical 
neurons.    
 
 
 
 
 
 
 119 
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Figure 2.   Critical role of Kv channels in 6-OHDA toxicity in GFP-DAT expressing cortical 
neurons.  A,  6-OHDA enhances voltage-dependent K+ currents in GFP-DAT expressing cortical 
neurons.  Bottom, mean current densities in wild type cortical neurons (left; n = 21), GFP-DAT 
expressing cortical neurons (middle; n = 16) and GFP-DAT expressing cortical neurons 
pretreated with the p38 inhibitor SB293063 (20 µM, right; n = 10).  All cells were treated with 
30 µM 6-OHDA for 15 min prior to recording (100 µM of the toxin led to very unstable 
recordings in GFP-DAT expressing neurons).  Currents were evoked by a voltage-step to +5 mV 
from a holding potential of –70 mV and normalized to cell capacitance (*p<0.05; 
ANOVA/Dunnet).  Top, representative whole-cell recordings from all three treatment groups.  
Currents were evoked by a series of 15 mV voltage steps to +35 mV from –70 mV.  Each set of 
traces is directly above its corresponding treatment group displayed in the bar graph. Calibration: 
5nA, 15ms   Note that the 6-OHDA-induced current surge could be blocked by the p38 inhibitor.  
B, 6-OHDA toxicity in GFP-DAT-expressing cortical neurons can be blocked by a K+ channel 
inhibitor.  GFP-DAT expressing cortical neurons were exposed 100 µM 6OHDA (15 min) in the 
absence or presence of either 10 mM TEA.  TEA treatment continued following toxin exposure. 
Viability was assayed by cell counting (GFP-positive cells) 24 hr. later as TEA interfered with 
the luciferase expression assay utilized above.  Note TEA protected cells from 6OHDA toxicity 
(n=3; *p<0.005, t-test).   
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Given these results, we investigated whether 6-OHDA could induce a K+ current surge in 
dopaminergic neurons, which express DAT endogenously.  In addition we tested whether K+ 
channel antagonists could prevent 6-OHDA toxicity in these cells.  Similar to what was observed 
in GFP-DAT expressing cortical neurons, 6-OHDA induced approximately a 2-fold increase in 
voltage-dependent K+ currents in dopaminergic neurons obtained from rat mesencephalic 
cultures (Figs. 3A and B).  In addition, this toxin (100 µM, 15 min) produced, approximately, 
50% dopaminergic neuronal cell death (Fig. 3C).  Importantly, 6-OHDA toxicity to 
dopaminergic neurons could be completely abrogated by 10 mM TEA (Fig. 3C).  We also 
observed nearly complete neuroprotection by the Kv2.1-selective blocker stromatoxin (ScTX, 
100 nM; Shiau et al., 2003; Grishin et al., 2005; Fig. 3C), but not by the K-ATP channel 
antagonist glibenclamide (1 µM; not shown).  These results indicate that 6-OHDA toxicity in 
dopaminergic cells activates a K+ current surge, reminiscent to what has been reported many cell 
types undergoing apoptosis (Yu, 2003; Bortner and Cidlowski, 2004).  Additionally, blocking K+ 
channels was neuroprotective, suggesting their critical role in the cell death process.        
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Figure 3.  Kv channels mediate 6-OHDA toxicity in dopaminergic neurons.  A,  6-OHDA 
enhances voltage-dependent K+ currents in mesencephalic dopaminergic neurons.  Currents were 
evoked from 13 DIV dopaminergic cells in mesencephalic cultures by a series of 10 mV voltage 
steps to +80 mV from a holding voltage of –80 mV under control conditions and following a 15 
min treatment with 30 µM 6-OHDA.  B, Mean ± s.e.m. current densities under control (n =10) 
and 6-OHDA treatment (n = 6) conditions.  Currents were evoked by a voltage step to +10 mV 
from a holding potential of –80 mV and normalized to cell capacitance (*p<0.001; t-test).  (g) 6-
OHDA toxicity in dopaminergic neurons can be blocked by TEA and stromatoxin, but not 
glibenclamide.  Mesencephalic cultures (15 DIV) were treated with 100 µM 6OHDA (15 min) in 
the absence or presence of 10 mM TEA, 100 nM stromatoxin (ScTX), or 1 µM glibenclamide 
(GLIB).  TEA, ScTX and GLB treatments continued following toxin exposure.  Cultures were 
fixed and immunostained for the presence of tyrosine hydroxylase (TH) 24 hours later. TH 
positive cells were then counted to assay DA cell survival.  Note TEA and STR, but not GLIB, 
protected cells from 6-OHDA toxicity (n=3-9; *p<0.01; ANOVA/Dunnet).  TEA, STR, and 
GLIB alone did not affect their viability (not shown).   
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DISCUSSION 
 
The selectivity of 6-OHDA for catecholaminergic neurons, and, especially, dopaminergic 
neurons, has been the subject of much debate due to the fact that this substance, and indeed all 
catecholaminergic-derived compounds, can auto-oxidize in physiological solutions to generate 
highly reactive quinones, as well as free radicals (Heikkila and Cohen, 1972; Rosenberg, 1988). 
Nonetheless, as early as 1970, it was suggested that 6-OHDA could selectively damage 
dopaminergic neurons in vivo due to the long-term depletion of central dopamine following 
intracerebral injections of the toxin (Uretsky and Iversen, 1970).  The sparing of 6-OHDA-
treated cultured dopaminergic neurons by DAT inhibitors provided unequivocal evidence that, at 
least under certain conditions, the selectivity of the toxin could be accounted by cellular uptake 
systems (Cerruti et al., 1993).  The results presented in this study corroborate this finding and 
indicate that under conditions where extracellular auto oxidation of 6-OHDA is not sufficient to 
induce non-selective injury (Hanrott et al., 2006), the presence of DAT activity can render the 
catecholaminergic derivative toxic, even in neurons not having an otherwise dopaminergic 
phenotype.  As such, DAT expression is not only sufficient, but a decisive component for the 
manifestation of selective 6-OHDA toxicity. 
 
Cellular K+ efflux is a requisite step for apoptosis to proceed in a variety cell death 
paradigms (Yu, 2003; Bortner and Cidlowski, 2004). The enhancement of potassium currents 
during the apoptotic process leads to a decrease in the concentration of this cation in the 
cytoplasm, which acts as a permissive cell death signal (Yu, 2003; Bortner and Cidlowski, 2004).  
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Our group has demonstrated that the K+ efflux accompanying oxidant-induced apoptosis is 
mediated by an enhancement of voltage-gated K+ currents (McLaughlin et al., 2001).  This 
phenomenon is triggered by the oxidative liberation of intraneuronal Zn2+, which leads to a p38-
mediated exocytotic insertion of Kv2.1-encoded channels (Aizenman et al., 2000; McLaughlin et 
al., 2001; Pal et al., 2003; Pal et al., 2006).  Recently, however, it was demonstrated that 
activation of ATP-sensitive potassium channels (K-ATP) was critical for the selective 
vulnerability of nigral dopaminergic neurons to the mitochondrial complex I inhibitors rotenone 
and 1-methyl-4-phenylpyridinium (Liss et al., 2005). However, the molecular link between K-
ATP channel activation and cell death pathways was not established, nor was it demonstrated 
whether these channels were also associated with 6-OHDA-induced toxicity.  The lack of 
neuroprotection by the K-ATP channel blocker glibenclamide observed in our studies indicates 
that these channels are not directly involved in the neurotoxicity induced by 6-OHDA in 
mesencephalic cultures.  Nonetheless, it is entirely plausible that different K+ channels are able 
to provide various exit routes for the cation, even in the same cell type, depending on the 
injurious stimulus.  While metabolically-sensitive K-ATP channels may be ideally suited to 
detect alterations in mitochondrial function by complex 1 inhibitors (Liss et al., 2005), voltage-
gated channels like Kv2.1, which are directly linked to oxidative signaling processes (Pal et al., 
2004), mediate 6-OHDA toxicity, and possibly the toxicity of other oxidants.  It is noteworthy 
that the general term “oxidative stress” is commonly and intimately associated with nigral cell 
death in the Parkinson’s disease literature (Abou-Sleiman et al., 2006).  The neuroprotective 
actions of ScTX, a Kv2.1-selective blocker, observed here, suggest that this channel mediates K+ 
efflux in dopaminergic neurons undergoing apoptosis, just like it does in cortical cells (Pal et al., 
2003).  Interestingly, Kv2.1 has recently been shown to be a major binding partner of DAT 
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(Maiya et al., 2006).  Our data strongly indicates that K+ channels may provide novel therapeutic 
targets for neuroprotection in Parkinson’s disease and related disorders.   
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